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Introduction
 Science is for everyone, and neuroscience – the study of the brain – is no different. 
Through the detailed study of our skull’s grey mass, through the uncovering of its 
intricate underlying mechanisms, we can amass more and more interest for this 
magnificent organ. We can share with the world how truly wonderful this organ 
really is, which makes us who we are from the moment of conception till shortly 
after the moment of our death. But as with any organ, our brains can also break, 
they can become diseased, disordered. And here, too, neuroscience is for the benefit 
of all. The detailed study of brain disorders can help uncover novel medications or 
therapies, and improve diagnoses of a whole range of brain problems, from a burn-
out to schizophrenia, from stroke to epilepsy. 
 What follows, is a general introduction of the topics under discussion in the 
present Thesis, an attempt to make digestible for the general public, for all, exactly 
what is studied, and why it is important that these topics are under investigation in 
the first place. I
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On white matter and myelination
 The human brain consists of approximately ~50% white matter, with the 
remainder being grey matter.1 While the grey matter contains the neuronal cells, the 
white matter contains the outgoing connections between the cell bodies, ensuring 
proper communication between various regions of the brain. Predominantly working 
on rodent models, we often forget that such a large proportion of the human brain 
is devoted to mere connections between brain areas. Imagine for a second that 
only half of a populated urban area consists of houses and companies, and that the 
remaining half consists of asphalted, 5-lane highways connecting everything! There 
must surely be a remarkable amount of ongoing traffic in the brain to justify such 
proportions.
 These remarkable numbers aside, the white matter of the brain predominantly 
consists of myelinated axons. The prototypical brain cell, the neuron, consists of 
three compartments2,3: a soma, dendrites and axons (Fig. 1.1). The soma is the 
neuronal cell body, which contains the nucleus with all genetic information, our 
genetic blueprint, as well as other important organelles important for survival of the 
cell. The dendrites are the receiving extensions, that interpret and forward incoming 
information originating from other cells in the direction of the soma. Finally, the 
axons, most important for the present Thesis, are the thin outgoing processes 
through which neurons transmit information to other neurons, or target organs 
(e.g., muscles). The axons come in a variety of shapes and sizes.4,5 Analogous to 
branching patterns of various species of trees, axons can feature only few branches 
– palm tree – or be widely and intricately branched – oak tree. Similarly, axons 
can range from a few millimeters in length to as long as ~1 meter or even more. 
In contrast to their length, axons are remarkably thin, ranging from ~0.1 µm in 
diameter to several tens of micrometers. 
 In the brain, signaling speed is a crucially important factor. Proper speed allows 
us to respond aptly to threats from outside, and evolutionarily could make the 
difference between life and death. One way to increase the speed of the signal 
traveling down the axon would be to simply increase the diameter of the axon 
(e.g. larger drain pipe can transport more water). This is why in general rapidly 
conducting axons tend to be larger than slowly conducting ones, and why some 
species have evolved giant diameter axons (as thick as ~1 mm!).6 Another strategy 
is to insulate the axon, so reduced amounts of signal are lost leaking through sides 
of the axon. Indeed, myelination is this insulating ensheathment of axons to ensure 
higher speed communication.7,8 The ensheathment itself is termed myelin, after the 
Greek word for marrow, and consists of up to 160 layers of concentrically wrapped 
membrane.9 A nice analogy can be drawn with heating pipes, that maintain their 
heat better when insulated. Or, in another traffic reference, layers of asphalt upon 
a road to allow for increased traffic speed. So, whereas unmyelinated axons can be I
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imagined as a dusty road on which a horse-wagon could traverse, myelinated axons 
give rise to asphalted highways for Ferrari-style trafficking. Importantly, an additional 
advantage of myelination over simply increasing axon diameter is space. Namely, 
equivalent speeds can be attained by a smaller diameter myelinated axon or a larger 
diameter unmyelinated axon. Thus, as with many other mechanisms in the brain, the 
process of myelination results in a continuous trade-off between costs and benefits: 
In the case of myelin, an efficient trade-off between space occupation and speed 
increases.
 Myelinated segments of axons, also termed internodes, are interrupted 
occasionally by short domains (~1 µm) termed nodes of Ranvier10. These nodes 
are highly excitable, meaning they can continuously and reliably regenerate the 
signal traveling down the axon, while within myelinated internodes, the signal flows 
passively along the axon with minimal loss in the outward direction. This peculiar 
jumping of the signal from node to node is known as “saltatory conduction”.7,8 Think 
of these nodal domains as places where you press the car gas pedal in really hard, 
and then take your foot of the gas again for a few seconds and just let the car roll. 
In traffic, this would obviously seem very odd. In the brain, this saltatory jumping of 
signals ensures energy-efficient, highly reliable propagation of signals. 
Figure 1.1. A neuron. The circular cell body (soma; black), along with its extensions. The dendrites (in black) convey 
incoming signals, whereas the highly branched axon (brown) will transfer information along to other cells.
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 Axons are commonly myelinated, but this is not ubiquitously observed around 
each and every axon throughout the brain. In white matter, regions dense in 
axonal fibers, estimates are that ~30% of axons still remain unmyelinated.11 The 
exact reasons why some axons in the brain show myelination while others do not 
remain unknown.12 Whether or not an axon becomes myelinated is at least in part 
explained by axonal morphology: In the peripheral nervous system, a clear relation 
has been shown between axon diameter and myelin status13, where axons with a 
diameter >1 µm show myelination, whereas thinner axons do not. To understand 
why this could be, a traffic analogy again helps out: It makes no sense to pave small 
walking paths in a particular forest with asphalt, so people can walk a bit faster. 
However, the moment a road becomes broad enough for a car, asphalt may start 
to have an advantage. Whereas in the peripheral nervous system this relationship 
between axonal morphology and myelin has been well-supported, in the central 
nervous system, however, this relation is less clear. Here, the diameter threshold 
lies somewhere between ~0.2 µm and ~0.8 µm13. Thus, a more complex interplay 
likely exists in the brain between axonal morphology, molecular cues, and neuronal 
activity. 
 Myelination in the central nervous system is produced by cells known as 
oligodendrocytes.14 Although approximately one-third of total cells in cortical 
grey matter is oligodendrocytes15, they constitute approximately ~70% of cells 
in human white matter regions.16 The predominant generation of myelin takes 
place during early postnatal development16, but more recent studies have shown 
that oligodendrocyte formation and de novo myelination continues to occur in 
adulthood.16–18 This continued maintenance of myelin can be affected by neuronal 
activity19,20 and experience18,21,22 and has given rise to a concept of myelin(ation) 
plasticity.23–31 This de novo myelination may even be required for learning new motor 
skills!32,33 Oligodendrocytes originate from oligodendrocyte precursor cells, a self-
renewing cell that constitutes the predominant population of dividing and renewing 
cells in the adult brain.34 These cells continuously scout the environment as well 
as self-repulse to form a generally homogeneous distribution across the cortex.35 
These facts in themselves are more hints that an optimal upkeep of myelin, by speedy 
replacement of mature oligodendrocytes, is important for continued functioning of 
the brain. Here, we could find another nice analogy in the maintenance of highway 
asphalt, without which serious potholes will arise and traffic can be severely affected.
 Besides increasing the speed of communication between distant brain areas, 
myelination has more recently been suggested to support axonal metabolic 
demand.36–38 In particular, oligodendrocytes provide axons – which travel over 
long distances – with important energy substrates through their myelinated 
ensheathments.36–38 Consequently, loss of white matter myelin not only causes 
decreases in speed with which signals travel, but could actually directly induce 
axonal death from energy insufficiencies.36–38 Thus, it is imaginable that through the 
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mechanism of metabolic support, myelination is actually simply crucial for survival. 
Indeed, patients suffering from diseases involving severe loss of myelin, for example 
in the disease known as ‘vanishing white matter disorder’, generally fail to survive 
beyond several years after disease onset.322 Although the metabolic function of 
myelination is drawing increased interest in the field, many questions are still left 
unanswered.
 Thus, myelinated axons constitute a large proportion of our brain volume, 
which rudimentarily induces speed advantages, but is much more than just speed. In 
addition, myelination is never done, but continuously updated, continuously changed. 
Importantly, with myelination playing a key role in the brain, in addition to severe 
changes in myelin having potentially severe effects, it is becoming more and more 
appreciated that subtle changes in myelination could actually play a prominent role 
in more ‘subtle’ diseases of the brain, such as psychiatric disorders.
On inhibitory, GABAergic interneurons
 In the brain, a continuous balance exists between the generation and stimulation 
of signals and putting a break on – inhibiting – these signals, a process generally 
known as the balance between excitation and inhibition. Only an optimal balance 
between excitation and inhibition can ensure proper functioning of our brains. 
Indeed, a disbalance between excitation and inhibition can potentially result in a 
wide range of neurological problems. On one hand, too much excitation, too much 
activation without sufficient braking, can lead to epilepsy.39 On the other hand, too 
much braking, too much inhibition, without proper activation, can have sedating 
effects40 (actually, when the doctor prescribes a regular sleeping pill, it increases 
these inhibiting effects). Conversely, either too little inhibition or too little excitation, 
respectively, can result in similar outcomes as too much excitation or too much 
inhibition! 
 This balance between inhibition and excitation, braking and speeding up, is carefully 
and continuously managed in the brain.41 In the cortex, approximately ~80% of the 
neurons are excitatory, while the remaining ~20% are inhibitory.42 These inhibitory 
cells make use of the neurotransmitter GABA, and thus are often referred to as 
GABAergic interneurons. Interestingly, these GABAergic inhibitory cells come in 
various shapes and sizes (Fig. 1.2)43,44, and it appears the brain has various ways of 
sculpting the inhibitory signals to balance out excitatory signals. An analogy can 
again be drawn with driving a car, where you generally have one single gas pedal, 
but various ways of braking. There is the foot-operated brake pedal, as well as the 
hand brake, and if that too fails the car can ultimately brake by making a sudden 
arboreal (tree-mediated) stop. So intricate is this inhibitory system in the brain, that 
inhibitory cells exist to inhibit other inhibitory cells!45 Activation of these particular 
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cells will reduce the signaling of other inhibitory cells, ultimately causing primary 
pyramidal cells to signal at higher rates.45 Imagine someone forcefully holding back 
your arm when you are trying to pull the hand brake, or forcefully holding back 
your leg reaching for the brake pedal. Complicated as this may seem, this process is 
actually thought to play a crucial role in the brain in health45 and disease.46
 One of the interneuron subclasses that are of particular interest in this Thesis 
are the fast-spiking, parvalbumin-positive interneurons.47 These cells account for 
approximately ~30% of interneurons, making them about ~5-10% of the total 
population of neurons in the cerebral cortex48. The fast-spiking interneurons are 
Figure 1.2. The colourful plethora of GABAergic interneurons. Each colour represents a different morphological cell 
type. Soma and dendrites are dark-shaded and axons are light-shaded. Abbreviations: SBC-like small basket-cell-like; 
eNGC elongated neurogliaform cell; MC Martinotti cell; NGC neurogliaform cell; HEC horizontal elongated cell; BTC 
bitufted cell; DC deep-projecting cells; BPC bipolar cells; BC basket cells; ChC Chandelier cell; SC shrub cell. Adapted 
from Jiang et al. 43.
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called fast-spiking because they are capable of signaling very rapid series of action 
potentials. Indeed, under certain behaviors these cells have the capability to signal 
at 200 Hz - once every 5 milliseconds.47 In addition, through their direct strong 
inhibition on cell bodies of primary cells, where action potentials are generated, 
as well as their large, unbiased connectivity49, fast-spiking interneurons are key 
regulators of neuronal circuits. In other words, activity of a fast-spiking interneuron 
can inhibit the activity of many surrouding cells. Imagine packed rush-hour traffic 
where all cars would be controlled by a single person handling a hand brake, at times 
fully stopping all cars. Provided all cars drive roughly at the same speed, this single-
person braking would induce highly synchronous car movements. Now imagine that 
this single-person braking and subsequent car-autonomous accelerating is happening 
at intervals of 200 Hz, and we have just modelled the fastest brain waves observable 
during an electroencephalogram (EEG)! Indeed, fast-spiking interneurons play an 
important role in synchronizing large groups of cells at higher frequency ranges 
(~40-200 Hz), known as the gamma range.50,51
 Altogether, inhibitory interneurons are crucial for brain functioning. They are 
highly diverse, but nonetheless equally important for optimal network functioning. 
Analogous to the impairments in myelination/white matter in the brain leading 
to brain disorders, abnormalities in inhibitory interneurons have been suggested 
to lead to all sorts of neurological or psychiatric problems.52–54 I have already 
mentioned epilepsy above, but more subtle problems in inhibitory cells have been 
linked to various other disorders of the brain, including, but not limited to, autism 
spectrum disorders, depression, bipolar disorder and schizophrenia.52–55 Exactly 
how GABAergic interneuron dysfunction contributes to each of these diseases, is 
currently still heavily under investigation.
On schizophrenia
 What the brain ultimately does is to try to make sense of the world. Contrary to 
the notion that the brain simply responds to outside events (stimulus-response)56, it 
is not so much continuously receiving, but it continuously interprets, it continuously 
predicts.56,57 The brain creates a reality based on predictions of what may likely 
happen, and then uses this predicted reality to maneuver our body through the 
world. Obviously, the ultimate goal of all this is simply to ensure survival of the body, 
against any means necessary. A particular disease in which this paragon of brain 
functioning is specifically impaired, is schizophrenia.
 Schizophrenia is a major psychiatric disorder that is quite common. The lifetime 
prevalence lies just under 1%58. Following diagnostic guidelines, schizophrenia entails 
what are known as positive, negative and cognitive symptoms. Positive symptoms, 
termed as such because they in general cannot be found in the healthy population, 
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include hallucinations and delusions. Negative symptoms, again termed as such 
because they tend to exemplify a reduction in functioning compared to healthy 
individuals, including a wide variety of symptoms ranging from reduced motivation, 
reduced feelings, and reductions in social interactions. The last group of cognitive 
symptoms affect working memory, attention, and executive functioning; crucial 
mental processes quite important for everyday functioning. Together, although each 
of these symptoms can be present in varying degrees, as well as change over time, a 
picture emerges of a disease that affects perception of reality, as well as conscious 
testing of reality.
 Schizophrenia is a profound burden for society, which stems from several factors. 
First, clinical onset of schizophrenia is situated relatively early in life around late 
adolescence/early adulthood, roughly occurring somewhere between ~18 and 25 
years of age.58 Following onset, schizophrenia generally follows a chronic course. 
Although severity of symptoms can wax and wane, spontaneous remission – the 
resolving of all symptoms – only happens rarely. Second, patients suffering from 
schizophrenia generally have reduced quality of life, higher unemployment levels, and 
reduced numbers of succesfull relationships, and well as a higher range of co-morbid 
problems.58 Finally, no curative treatment yet exists for this disease, and current 
treatment options are mainly focused on alleviating the most prominent – positive 
– symptoms. Together, this combination of early onset, chronic course, and few truly 
successful treatment options make schizophrenia a significant burden for society.
 Although schizophrenia was coined over a century ago59, the underlying brain 
pathology is still unknown. On one hand this is surprising, as schizophrenia is one 
of the most studied disorders of the brain: A quick search on PubMed for the term 
‘schizophrenia’ results in ~135.000 hits (!), a number higher than for Alzheimer’s 
disease (~100.000), Parkinson’s disease (~84.000), or autism (~45.000). On the 
other hand, if schizophrenia really evolves around the continuous interpretation and 
assessment of our individual environments, on questioning what is real and what 
is not, what is likely to happen and what is not – the apex functions of the human 
brain – it is not surprising that we still have not figured this disease out. It could 
be that neuroscientific techniques are currently still insufficient to start unravelling 
schizophrenia neurobiology. Or, we just have not been looking in the right place.
 Nevertheless, what we do know, is that schizophrenia has something to do 
with dopamine.60 Dopamine is one of the main neurotransmitters of the brain – a 
chemical released by neurons to signal to other cells.61 In popular media, dopamine 
is often referred to as the ‘happiness hormone’, as activation of dopaminergic cells 
and release of dopamine is related to rewarding behavior. In schizophrenia, various 
lines of evidence have shown that overactivation of dopaminergic signaling leads 
to (at least the positive) symptoms of the disease.62 First, all known antipsychotics 
block dopamine signaling at the D2 receptor, and their clinical efficacy is related to 
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their binding to this receptor. Next, dopaminergic agonism can lead to psychotic 
symptoms in healthy controls, and greatly exacerbates symptoms in patients with 
schizophrenia. Finally, PET imaging studies have directly shown elevated dopamine 
signaling in patients. Exactly how aberrant signaling leads to schizophrenia symptoms, 
is widely debated.63 Beside dopamine dysfunction, various other pathways have 
been implicated in schizophrenia pathophysiology64–66, but the dopamine system 
has remained the most widely supported theory. Overall, it appears nature has a 
particularly cruel sense of irony that such a major debilitating psychiatric disorder 
can arise from increased signaling of a happiness hormone.
 However, it may come to pass, to study schizophrenia, some would say67, is to study 
what makes us human. To study schizophrenia means to study perception, thought, 
testing of reality, consciousness and awareness, social interaction, motivation. Thus, 
to study schizophrenia means to study the entirety of what the brain is made for, 
every cell, every molecule, every brain region. So, if we study schizophrenia, and 
study it thoroughly, whatever we uncover, will keep advancing our understanding of 
the brain in a significant manner. This is very much in line with the saying “shoot for 
the moon, even if you miss, you will still be among the stars holy shit you’re in space.”
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Scope of this Thesis
 The present Thesis brings the various topics introduced earlier – myelination, 
inhibitory interneurons, and schizophrenia – together in a single Thesis. I will describe 
how the former two (myelin, interneurons) quite unexpectedly come together in 
a single phenomenon termed GABAergic interneuron myelination, a phenomenon 
remarkably understudied, and one that potentially has a key role to play in the 
pathophysiology of the latter (schizophrenia).
 Chapter 2 describes a review on schizophrenia, where dysfunction in 
both GABAergic inhibitory interneurons as well as dysfunctional myelination 
independently have previously been implicated. I combine these findings to put 
forward the hypothesis that GABAergic interneuron myelination could play a pivotal 
role in schizophrenia pathophysiology.
 Chapter 3 examines the extent of interneuron myelination in the cerebral cortex 
of mouse and human. I find that a large proportion of cerebral cortex myelin 
encompasses GABAergic interneurons and that nearly every PV+ interneuron 
shows a proximal pattern of sparse myelination.
 Chapter 4 examines the role of neuronal activity in myelination of PV+ 
interneurons. I find that chronic chemogenetic activation in adult prefrontal PV+ 
cells leads to more extensive myelination, which appears mediated by changes in 
axonal branching.
 Chapter 5 examines the role of axonal morphology in governing interneuron 
myelination. I find that PV+ interneuron myelination is strongly associated with axonal 
morphology. Bi-directional axonal manipulations coordinately change myelination, 
while manipulations of normally unmyelinated SOM+ interneurons lead to their de 
novo myelination. Across both interneuron subclasses and cell size-varying genetic 
manipulations, the same set of model parameters retains high predictive validity.
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Abstract
 Schizophrenia is a debilitating psychiatric disorder characterized by positive, 
negative and cognitive symptoms. Despite more than a century of research, the 
neurobiological mechanism underlying schizophrenia remains elusive. White 
matter abnormalities and interneuron dysfunction are the most widely replicated 
cellular neuropathological alterations in patients with schizophrenia. However, a 
unifying model incorporating these findings has not yet been established. Here, we 
propose that myelination of fast-spiking parvalbumin (PV) interneurons could be an 
important locus of pathophysiological convergence in schizophrenia. Myelination of 
interneurons has been demonstrated across a wide diversity of brain regions and 
appears highly specific for the PV+ interneuron subclass. Given the critical influence 
of fast-spiking PV+ interneurons for mediating oscillations in the gamma frequency 
range (~30-120 Hz), PV+ myelination is well positioned to optimize action potential 
fidelity and metabolic homeostasis. We discuss this hypothesis with consideration 
of data from human postmortem studies, in vivo brain imaging and electrophysiology, 
and molecular genetics, as well as fundamental and translational studies in rodent 
models. Together, the parvalbumin interneuron myelination hypothesis provides a 
falsifiable model for guiding future studies of schizophrenia pathophysiology.
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Introduction
 Schizophrenia is a chronically debilitating psychiatric disorder with a lifetime 
prevalence of ~1%.68 Patients with schizophrenia classically exhibit a constellation 
of positive, negative, and cognitive symptoms.64 Although many theories have been 
proposed, the precise neurobiological mechanism underlying schizophrenia has 
remained elusive.  The most widely described models have been the dopamine60 
and glutamate hypotheses69, although in recent years models regarding interneuron 
dysfunction70 and myelination abnormalities71 have gained increasing support.
 In this review, we hypothesize that previous observations of interneuron 
dysfunction and myelination abnormalities in schizophrenia might converge on the 
altered myelination of fast-spiking parvalbumin-positive (PV) interneurons. First, we 
summarize the major evidence supporting interneuron dysfunction and myelination 
abnormalities in schizophrenia. Next, we summarize electron microscopy and 
immunofluorescence studies that convincingly demonstrate interneuron myelination, 
which frequently occurs on fast-spiking PV+ interneurons. Finally, we discuss 
how impairments in myelination of PV+ interneurons could lead to consequent 
abnormalities in gamma synchronization and ultimately give rise to the symptoms 
which define schizophrenia.
Parvalbumin interneuron dysfunction in schizophrenia
 Deficits in GABAergic signaling have been widely proposed as a fundamental 
pathophysiological mechanism underlying schizophrenia.72 More specifically, several 
recent lines of evidence from human post mortem studies, genetics, and in vivo 
electrophysiological recordings in patients and translational mouse models have 
identified fast-spiking PV+ interneurons as the major interneuron cell type affected 
in schizophrenia (Table 2.1). 
 Expression of GAD67 – the predominant GABA synthesizing enzyme – has 
consistently been found to be reduced at both the mRNA and protein levels in 
several brain regions of patients with schizophrenia, a finding that has been well 
controlled for confounding factors.73–79 Downregulation of GAD67 mRNA levels 
have been reported in ~30% of dorsolateral prefrontal cortex interneurons80,81 and 
entirely undetectable in ~50% of PV interneurons.82 Expression of PV mRNA83–85 
and protein86 is also reduced in schizophrenia, while the neuronal density of cortical 
PV+ interneurons is unchanged.(87–90, but see also 52) Since the expression of both PV and 
GAD67 are experience-dependent91 – and GAD67 and PV expression are highly 
correlated91 – their shared downregulation suggests a functional impairment of fast-
spiking interneurons.92 Morphologically, PV+ cell inputs onto pyramidal neurons 
have no discernible alterations86, suggesting a primary functional abnormality of 
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PV+ interneurons. Consistent with these neuropathological findings, in vivo PET 
imaging has demonstrated widespread alterations of cortical GABA transmission in 
schizophrenia, a finding that was most prominent in the subset of patients who were 
antipsychotic-naïve.93 Together, these results provide compelling evidence of cortical 
PV+ interneuron dysfunction in schizophrenia.
 PV+ interneurons are essential in generating cortical oscillations in the gamma 
range (~30-120 Hz), mediated by synchronized inhibition of large pyramidal cell 
ensembles.50,51 Through rhythmic perisomatic inhibition onto surrounding pyramidal 
cells, synchronous ensembles of PV+ cells evoke high-frequency gamma oscillations 
in the cerebral cortex.94–96 Gamma synchrony has been shown to function critically 
across a range of cognitive functions, including working memory and attention97, with 
well-replicated abnormalities in schizophrenia.35,5 Abnormalities in other frequency 
bands such as theta and alpha have also been reported in schizophrenia, but the 
neural mechanisms underlying these frequencies remain less well understood.35 
 Electroencephalographic (EEG) studies in schizophrenia have shown a reduced 
amplitude and impaired phase locking of gamma band activity over frontal areas 
while assessing working memory and executive functioning tasks.35 Although some 
Interneuron Dysfunction Myelination Abnormalities
Schizophrenia Age of 
Onset
Maturation of PV+ cells64 Peak of myelination126
Emergence of high frequency
oscillations98 
Development of frontal grey matter 
oligodendrocytes16
Post Mortem Findings PV mRNA and protein decreased82-86 Abnormal myelin/oligodendrocyte gene 
expression127-134
GAD67 mRNA and protein 
decreased73-82
Lower oligodendrocyte numbers136-153
Transcriptional changes in PV+ cells320 Ultrastructural abnormalities152-153
Transcriptional changes in 
oligodendrocytes138
Human In Vivo Findings Activity-dependent EEG 
abnormalities70 *
Lower FA values on DTI108–121*
MRS-based GABA impairments93
Genetic Findings CNVs in GABAergic signaling99 GWAS common variants myelin/
oligodendrocyte gene sets155-158
GWAS common variants enriched in mature 
oligodendrocytes159
Table 2.1. Comparison of interneuron and myelination data for schizophenia. *Present in first-episode, drug-naive 
patients. Abbreviations: CNV, copy number variation; DTI, diffusion tensor imaging; EEG, electroencephalography; FA, 
fractional anisotropy; GABA, gammaaminobutyric acid; GWAS, genome-wide association study; mRNA, messenger 
RNA; MRS, magnetic resonance spectroscopy; PV, parvalbumin.
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studies have observed concurrent increases in gamma band activity at rest, this 
finding has been less well replicated.35 Taken together, impairments of in vivo gamma 
oscillations in patients with schizophrenia are highly consistent with the PV+ 
interneuron abnormalities observed by postmortem histopathology.
 The classical onset of schizophrenia occurs within a relatively narrow window 
of neurodevelopment, between approximately 18 and 25 years of age.64 This 
late adolescent age of onset has often been attributed to the ongoing functional 
maturation of the brain during this neurodevelopmental critical period.64 Specifically 
in late adolescence, rates of synaptic pruning and myelination become asymptotic 
for which impairments in these processes have been linked to the disease onset.64 
Notably, maturation of gamma band synchrony also occurs during late adolescence98 
which coincides developmentally with the clinical onset of schizophrenia.
 In addition to in vivo brain imaging, EEG recordings, and postmortem 
histopathology, molecular genetic studies of schizophrenia have also revealed 
an important contribution of interneuron dysfunction to the pathophysiology 
of schizophrenia. A recent genetic study of copy number variation (CNV) has 
now provided causal evidence for GABAergic dysfunction in the etiology of 
schizophrenia.99 In this study, Pocklington et al. (2015) performed a functional gene 
set analysis for enriched biological mechanisms using the largest schizophrenia case-
control CNV dataset thus far reported and found that case CNVs were significantly 
enriched for genes responsible for inhibitory neurotransmission (in particular the 
GABAa receptor complex), glutamatergic neurotransmission, long-term synaptic 
plasticity, and associative learning. The genetic variant with the highest known risk 
for schizophrenia is the 22q11 microdeletion which has a penetrance of ~40% 
penetrance100,101. Transgenic mouse models have been generated to investigate the 
underlying neurobiology conferred by 22q11 microdeletion. Df(16)A mice harboring 
a 27-gene microdeletion syntenic to a 1.5 Mb region of human 22q11.2 exhibit 
similar brain abnormalities as found in human 22q11 microdeletion carriers, including 
cortico-cerebellar, cortico-striatal and cortico-limbic circuits.102 Moreover, multiple 
different mouse models of 22q11 microdeletion have replicated a cell-type specific 
impairment in PV+ interneurons and disrupted local synchrony of neural activity, 
consistent with the deficit in gamma oscillations observed in schizophrenia.103–105
 Evidence for interneuron dysfunction in schizophrenia has also been supported 
by a wide variety of non-genetic rodent models.106 The major examples include 
pharmacological NMDA receptor antagonism and neurodevelopmental 
immunological challenge, both of which consistently exhibit synaptic and network 
abnormalities reminiscent of schizophrenia pathophysiology. Specifically, these 
studies have identified electrophysiological changes in local microcircuit connectivity 
and synaptic plasticity, with alterations in excitation/inhibition balance and gamma 
band synchronization. 
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 Taken together, the combination of genetic, post mortem, and in vivo 
electrophysiological and functional imaging results from human clinical studies of 
schizophrenia converge with translational rodent modeling to identify fast-spiking 
PV+ interneuron dysfunction as a major pathophysiological mechanism underlying 
schizophrenia etiology.
Myelination abnormalities in schizophrenia
 Independent of PV+ interneuron alterations, myelination abnormalities have 
also been extensively implicated in schizophrenia through both in vivo brain imaging 
and postmortem assessments (Table 2.1). Numerous diffusion tensor imaging 
(DTI) studies have been published for schizophrenia (reviewed in 71), of which the 
overwhelming consensus has been the association of schizophrenia with globally 
decreased fractional anisotropy (FA). Notably, the decrease in FA appears to become 
more severe with increasing age and illness duration.107 Many of the early brain 
imaging studies of schizophrenia were performed in cohorts with extensive histories 
of psychotropic medication, inpatient hospitalization, smoking, and medical co-
morbidities, which could have a confounding deleterious influence on white matter 
integrity. Thus, an important question has been whether myelination abnormalities 
are already present in drug-naïve patients with first-episode schizophrenia who have 
never received psychotropic medication. Recently, several DTI studies have been 
performed in such cohorts,108–121 holding the potential to directly evaluate these 
potential confounders. Indeed, across a range of different methodologies, studies of 
drug-naïve first-episode schizophrenia have consistently demonstrated similar, albeit 
less severe, myelination abnormalities as observed in chronic illness. Importantly, 
these studies confirm that a global impairment of myelin integrity is already present 
at the time of the initial clinical onset of psychotic symptoms in schizophrenia. 
Accordingly, these findings support a model by which myelination abnormalities 
function critically in the pathophysiology of schizophrenia.
 The late adolescent age of onset for schizophrenia closely overlaps with the 
maturation of prefrontal cortex myelination.122 The time course of myelination 
in humans has been elegantly detailed through longitudinal in vivo imaging and 
postmortem cross-sectional studies demonstrating rapid early postnatal white 
matter development in the first 12 months123, followed by a slower but steady 
increase until late adolescence.124,125 Comparative mammalian evolutionary studies 
have demonstrated that humans exhibit a particularly extended neurodevelopmental 
time course of neocortical myelination.126 While myelination in humans peaks in 
late adolescence, for non-human primates and rodents the peak of myelination 
occurs significantly earlier in development.126 Together, the current best evidence 
demonstrates that the onset of schizophrenia closely coincides with the peak of 
myelination in human brain development. 
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 In addition to the well-replicated finding of in vivo white matter abnormalities in 
schizophrenia, postmortem gene expression analyses have also identified alterations 
in myelination regulatory pathways. Several studies have reported a broad reduction 
in the expression of genes with demonstrated function in the oligodendrocyte 
lineage.127–134 Using microarray-based transcriptome analysis with qPCR validation, 
abnormalities in oligodendrocyte lineage genes have been found in both frontal white 
and grey matter127,128,131, subcortical regions129,132, occipital cortex133, and temporal 
cortex134. The alignment between in vivo brain imaging findings and postmortem 
gene expression analyses is highly consistent with the central importance of 
myelination abnormalities in schizophrenia pathophysiology. Notably, many of the 
same oligodendrocyte and myelination genes found to be altered in schizophrenia 
also exhibit consistent increases during normal brain development precisely during 
adolescence,135 again consistent with the association between the late adolescent 
age of onset in schizophrenia and the peak of myelination.
 Compared to the abundance of brain imaging and gene expression studies 
of myelination and oligodendrocytes, post mortem stereological analysis of 
oligodendrocyte lineage cell types are scarce. From the few studies that have 
been performed, stereological quantification of myelinating oligodendrocytes have 
revealed widespread reductions in schizophrenia (Table 2.1).136–146 Reductions in 
oligodendrocyte numbers have been shown in the white and grey matter of BA9,136–
140 white and grey matter of BA10,141,142 posterior hippocampal subregion CA4,143 
internal capsule,144 nucleus basalis,145 and anterior thalamic nucleus146. In contrast, 
oligodendrocyte numbers appear unchanged within the substantia nigra,147 callosal 
genu,148 and subgenual cingulum.148 Furthermore, one study failed to find differences 
in oligodendrocyte number within any subregion of the hippocampus.149 In addition, 
a few studies have reported seemingly paradoxical increases in the number of 
myelinating oligodendrocytes in frontal white matter150 and basolateral amygdala.151 
Although caution is warranted given the limited number of studies and differences 
in methodology, the emerging picture is one of small but consistent reductions 
of myelinating oligodendrocytes in schizophrenia (~14% reduction136,137,139–146). 
However, an important unanswered question is whether the observed reduction 
of myelinating oligodendrocytes is cell-type specific or also extends to other less 
differentiated cell types within the oligodendrocyte lineage. 
 A very recent study is the first to report a stereological analysis of 
oligodendrocyte precursors cells (OPCs)138, also known as NG2 cells due to their 
high expression of the neuron-glial antigen 2 (NG2) protein. The number of frontal 
white matter OPCs were unchanged while the total population of oligodendrocyte 
lineage cells was reduced, thereby suggesting that the reduction in oligodendrocyte 
lineage cells occurs predominantly in more differentiated cell types. Furthermore, 
oligodendrocyte cell type-specific transcriptome analysis and immunohistochemical 
labeling independently suggests an impairment of OPC differentiation towards 
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mature oligodendrocytes. Given that OPCs are the exclusive progenitor cell 
population of myelinating oligodendrocytes, more knowledge of the regulation 
and function of OPCs in schizophrenia would better clarify whether the observed 
reductions in myelinating oligodendrocytes are a consequence of abnormalities that 
have occurred upstream in the myelination lineage or the consequence of a cell-type 
specific loss of myelinating oligodendrocytes.
 Two studies have examined myelination at the ultrastructural level in 
schizophrenia. The major findings involved myelinated axons and oligodendrocytes, 
in frontal cortex white and grey matter.152,153 The observed pathological features 
included alterations in the morphology of the myelin sheath and the frequency of 
axonal degeneration within morphologically-intact myelin segments. Notably, the 
effect sizes were larger in grey matter compared to white matter regions.152,153 
With regard to in vivo and postmortem findings, the possibility remains that the 
observed myelination abnormalities in schizophrenia could result from primary 
and/or secondary disturbances of neuronal signaling.154 Therefore, genetic studies 
provide a unique opportunity to investigate etiological mechanisms of schizophrenia 
while avoiding the potential confounds of antipsychotic medication and secondary 
disease effects. Notably, recent studies have shown using genome-wide association 
study (GWAS) data that myelination/oligodendrocyte genes sets are significantly 
associated with both the risk of schizophrenia155–157 and the severity of deficits in 
white matter integrity.158 Moreover, the most recent GWAS results for schizophrenia 
exhibited a significant enrichment of genes expressed in mature oligodendrocytes,159 
together suggesting a convergence of common variant risk on myelination.
 Although important questions remain unanswered, GWAS results implicating 
myelination as an etiological mechanism, in vivo imaging demonstrating well-
replicated myelination abnormalities, human postmortem histopathology showing 
replicated decreases in the number and ultrastructure of oligodendrocytes, and gene 
profiling studies demonstrating replicated changes in oligodendrocyte expression, 
together provide compelling support for myelination as a major pathophysiological 
mechanism in schizophrenia. 
Myelination of parvalbumin interneurons
 An increasing number of studies has revealed the unexpectedly extensive 
myelination of interneurons (Table 2.2), predominantly fast-spiking PV+ basket 
cells, in cortical grey matter and other regions throughout the brain160–186 (Table 
2.3). Myelination of cortical GABAergic basket cells was first reported over 30 
years ago in the cat visual cortex by electron microscopy.161,172,180 In non-human 
primates, GABAergic axons in layers III-V are myelinated in sensorimotor162,163,186 
and temporal182 cortices, a finding that had already been hinted at several years 
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earlier.185 Myelinated GABAergic interneurons were subsequently identified in the 
cat superior colliculus174, as well as in the red nucleus165 and hypoglossal nucleus164 
of the monkey. Although the relative distribution of myelination across interneuron 
subtypes has not yet been quantitatively determined, a consistent qualitative 
observation has been that a high proportion of the GABA-labeled terminals of 
myelinated axons exhibit localized somatic targeting suggestive of basket cells.106 
Moreover, direct ultrastructural evidence for basket cell myelination has also been 
demonstrated in visual cortex of cat98,99 and rat112.
 PV-positive myelinated fibers in the adolescent mouse visual cortex were 
reported to be abundantly present by fluorescence confocal microscopy.160 Basket 
cells have been reported to be myelinated in occipital167 and somatosensory169 
cortex of the rat. PV-immunoreactive myelinated neurons have been identified in the 
rat entorhinal cortex175, hippocampus178 and striatum.179 In the rat entorhinal cortex, 
myelinated PV+ axons were found extensively across all cortical layers, interspersed 
Study Species Region Technique Conclusion
Somogyi et al.180 Cat Visual Cortex EM Presence of single myelinated GAD+ cells
Mize et al.174 Cat Superior 
Colliculus
EM Presence of myelinated GABAergic neurons
Ong et al.182 Human Frontal cortex EM Presence of several myelinated GAT-1 axons
Ong et al.182 Monkey Temporal cortex EM Presence of several myelinated GAT-1 axons
Hendry et al.106 Monkey Sensorymotor 
cortex
EM Presence of several myelinated layer III–V
GABAergic neurons
DeFelipe et 
al.107
Monkey Somatosensory 
cortex
EM; [3H]
GABA tracing
Presence of several myelinated GABAergic 
neurons
DeFelipe et 
al.108
Monkey Sensorymotor 
cortex
EM Presence of several myelinated layer III–V
GABAergic neurons
Takasu et al.109 Monkey Hypoglossal 
nucleus
EM Presence of several myelinated GABAergic 
neurons
Ralston et al.110 Monkey Red nucleus EM Presence of several myelinated GABAergic 
neurons
Jinno et al.111 Rat Hippocampus SCT; IF Presence of several myelinated GABAergic
projection neurons
De Biasi et al.113 Rat Thalamus EM Presence of a few myelinated GABAergic axons
Conti et al.114 Rat Cortex EM Presence of several myelinated GAT-2 positive
axons
Roberts et al.121 Rat Inferior colliculus EM Presence of several myelinated GABAergic 
neurons
Sawyer et al.120 Monkey Thalamus EM; LM Presence of several myelinated GABAergic 
neurons
Table 2.2. Studies reporting myelination of GABAergic neurons. Abbreviations: EM, electron microscopy; GABA, 
gamma-aminobutyric acid; GAD, glutamic acid decarboxylase; GAT, GABA transporter ; IF, immunofluorescence; LM, 
light microscopy; SCT, single-cell tracing.
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with unmyelinated axonal segments.175 Furthermore, myelinated GABAergic neurons 
have been identified in the rodent hippocampus166,173, thalamus168,176, and inferior 
colliculus177, although these studies were performed largely without interneuron 
subtype-specific labeling.175 However in one notable exception, myelinated 
rat hippocampal GABAergic neurons were confirmed as PV+ interneurons173. 
Moreover, the vast majority of septohippocampal PV, but not cholinergic, fibers are 
myelinated.170,171,187
 Few studies have reported attempts to examine myelination of interneurons in 
human cortex. Myelination of PV+ cells in the human hippocampus183 and claustrum184 
has been confirmed by electron microscopy. Furthermore, myelinated GABAergic182 
interneurons have been incidentally observed in the human frontal cortex, including 
with PV+ interneuron subtype specification181. Thus, although sparsely documented, 
PV+ interneuron myelination appears to be widespread throughout the brain and 
evolutionarily conserved among mammals. More detailed and comprehensive studies 
are required to quantify the relative proportion of myelinated PV+ interneurons, 
their developmental time course of myelination compared to pyramidal neurons, 
Study Species Region Technique Conclusion
Micheva et al.216 Mouse Somatosensory 
cortex
Array 
tomography; 
EM
~25–50% of myelinated axons in the neocortex 
are GABAergic, of
which nearly all are PV+
McGee et al.160 Mouse Visual cortex IF ~ One-third of myelinated axons are PV+
Somogyi et al.161 Cat Visual cortex EM Presence of several myelinated basket cells
Somogyi et al.172 Cat Visual cortex EM Presence of two myelinated basket cells
Chung et al.181 Human Frontal cortex IF; CLARITY Single figure of myelinated PV+ axons
Seress et al.183 Human Hippocampus EM Presence of a few myelinated PV+ axons
Hinova-Palova 
et al.184
Human Claustrum EM; IF Presence of several myelinated PV+ axons
Peters et al.167 Rat Visual cortex EM Presence of several myelinated basket cells
Wouterlood et 
al.175
Rat Entorhinal 
cortex
EM Extensive presence of myelinated PV+ axons 
throughout all cortical
layers
Gartner et al.170 
Brauer et al.187
Rat Hippocampus IF; EM Majority of septohippocampal PV+ fibers show 
myelination, but not
cholinergic ones
Kita et al. 179 Rat Neostriatum EM; LM Presence of several myelinated PV+ neurons
Freeman et 
al. 173
Rat Hippocampus (in 
vitro)
Hippocampal 
Cultures; IF
Myelination of PV+ neurons in vitro
Katsumaru et 
al.178
Rat Hippocampus EM Presence of myelinated PV+ neurons
Hu et al.223 Rat Hippocampal 
dentate gyrus
IF No myelinated PV+ fibers present
Table 2.3. Studies reporting myelination of PV+ interneurons. Abbreviations: EM, electron microscopy; IF, 
immunofluorescence; LM, light microscopy.
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subcellular distribution of segmental myelination, and brain region distribution, as 
well as the functional neurophysiological implications of interneuron myelination.
 Notably, we have not found any report demonstrating myelination of cortical 
somatostatin (SOM) or neuropeptide Y (NPY) interneurons, despite numerous 
electron microscopic studies in a variety of mammalian species188–191, thereby 
suggesting a high specificity for the PV+ subclass of GABAergic interneurons. 
In contrast, non-PV interneuron myelination has been sporadically reported in 
subcortical regions, for example in sparse small-diameter axons of the rat internal 
capsule192 and in the cat claustrum.193 This suggests that at least within the cerebral 
cortex, PV cells are the predominant myelinated interneuron subtype while in 
subcortical brain regions the cell-type distribution of myelinated interneurons may 
be less strict.
 Recently, it has been shown that PV+ interneurons establish direct functional 
soma-targeted contacts with OPCs in cortical layer V.194 Synaptic input from 
local GABAergic interneurons has been shown to dynamically regulate OPC 
differentiation to oligodendrocytes.195 OPCs receive strong GABAergic synaptic 
input from PV+, and to a lesser extent from non-PV+, interneurons.194 Notably, 
the peak neurodevelopmental period of interneuron-OPC connectivity (p10 - p14) 
would thus position interneuron myelination precisely in the window following the 
initial onset of GABAergic burst firing, but prior to maturation of high-frequency 
gamma oscillations.196 This also closely aligns with the timing of human frontal cortex 
oligodendrocyte development which plateaus in early adulthood16 and is highly 
distinct from white matter development in which oligodendrocytes have already 
reached their maximum number by approximately five years of age.16 Moreover, in 
further contrast to white matter, frontal cortex grey matter exhibits a substantial 
turnover of oligodendrocytes and myelin that persists throughout adulthood.16 
Analogously, rodent studies have demonstrated that OPCs exhibit important 
distinctions in their physiology, proliferation, and differentiation between grey and 
white matter in rodents.197 Therefore, regional differences in human OPCs are also 
not unlikely.
 Interestingly, direct contacts of interneurons onto OPCs198 are only locally 
distributed, reaching a typical maximum distance of ~50-70 µm194, which is notably 
highly similar to the estimate for the maximal length of OPC processes. An interesting 
question remains why interneurons have such a restricted spatial localization of 
their connectivity onto OPCs, since PV+ cells establish synaptic contacts with 
pyramidal cells across a distance approximately six times larger.199 One possibility 
is that OPCs utilize reciprocal synaptic input to regulate their proliferative drive. 
Alternatively, it may be that myelination preferentially occurs on proximal axonal 
segments, in close apposition to the observed localization of OPCs and allowing for 
rapid differentiation to oligodendrocytes with enhanced myelination plasticity.
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Potential functions of interneuron myelination
 PV+ interneurons function to synchronize pyramidal cell ensembles, and thereby 
generate high-frequency oscillations.200 Since cortical PV+ axonal arborization 
is widely ramified and distributed over distances up to 300 µm199, there might 
be considerable benefits of myelination for optimizing the fidelity of fast action 
potential transmission. Indeed, computational modeling has suggested a unique 
contribution of (interneuron) conductance delays in the dynamics of gamma 
frequency oscillations.201 Evidence exists that nodes of Ranvier begin forming prior 
to the onset of myelination173, a mechanism specific for GABAergic neurons, which 
enhances axonal conduction of action potentials without myelin. Thus, in addition to 
simply increasing the speed of action potential propagation, myelin could function to 
ensure the integrity of precisely timed action potentials, as has been proposed for 
myelinated excitatory axons.202 Myelin plasticity would then have the potential to 
support the local synchronization of action potentials necessary for generating high-
frequency oscillations.203 Indeed, myelinated axons exhibit both higher conduction 
velocities and enhanced long-range coherence.204 Although non-PV+ cortical 
interneuron subtypes (e.g. SOM, VIP) exhibit synaptic connectivity across similar 
distances199, their lack of influence in maintaining high-frequency oscillations is 
consistent with their absence of myelination. Furthermore, the activity-dependence 
of myelination25 might permit dynamically-regulated influences on the fidelity of fast 
action potential transmission and high-frequency oscillations.
 Furthermore, myelin could provide metabolic and trophic support for 
energetically-costly PV+ cells. PV+ cell characteristics, including high-frequency 
spiking and rapid action potential kinetics, require a particularly high energy utilization 
through predominantly mitochondrial oxidative phosphorylation.205 Gamma band 
synchrony, closely linked to cognition, is highly sensitive to metabolic disruption. 
Furthermore, compared to pyramidal cells, PV+ cells exhibit high densities of 
mitochondria and expression of cytochrome c and cytochrome c oxidase, proteins 
crucial for the electron transport chain. Moreover, PV+ cell-specific disruption of 
cytochrome oxidase assembly leads to changes in PV+ cell intrinsic excitability, 
afferent synaptic input, and gamma/theta oscillations, as well as schizophrenia-related 
behavioral impairments in sensory gating and social behavior.206 During gamma 
oscillations, peak oxygen consumption approaches the demand observed during 
seizures and mitochondrial oxidative capacity operates near its functional limit.205 
Metabolic and trophic support conferred by myelination36,37 might therefore allow 
PV+ axons to optimize their energy utilization. Consistent with the importance of 
myelination in regulating axonal energy metabolism is the considerable discrepancy 
of mitochondria content (30-fold) in myelinated versus unmyelinated pyramidal cell 
axons207 which is also paralleled in PV+ interneuron axons. Myelin has been proposed 
to regulate axonal energy metabolism via the monocarboxylate transporter 1 
(MCT1) channel143. Furthermore, the high peak oxygen consumption of PV+ cells 
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during gamma band synchrony could require the additional lactate provided by 
oligodendrocytes. 
 Taken together, the electrophysiological dynamics of fast-spiking PV+ 
interneurons, their dense branching onto pyramidal neurons requiring finely-tuned 
temporally-synchronized inhibition, and their high energy consumption are likely 
interdependent mechanisms governed by PV+ interneuron myelination.
Implications for Schizophrenia
 Both interneuron dysfunction and myelination abnormalities have been 
independently proposed as important contributors to the underlying pathophysiology 
of schizophrenia. These mechanisms have each amassed convincing support from 
post mortem histopathology, in vivo imaging and electrophysiology, genetics, and 
neurodevelopment (Table 2.1). However, neither hypothesis is capable of accounting 
for the full set of clinical research findings in schizophrenia. In contrast, interneuron 
myelination brings together both of these models, explains a more comprehensive 
portion of the existing data, and offers a well-defined falsifiable model.
 Impairments of PV+ interneuron myelination could directly contribute to 
schizophrenia through several mechanisms. Impaired action potential fidelity, energy 
restrictions during highly-demanding cognitive tasks, aberrant axonal branching, and 
a higher occurrence of ectopic action potentials could each independently, or in 
combination, disrupt inhibitory network function. Such changes to PV+ interneurons 
would likely result in abnormalities of local gamma synchronization, with a potential 
further impact on the integrity of long-range thalamocortical and corticostriatal 
circuits, and striatal dopamine signaling, ultimately giving rise to schizophrenia 
symptoms. 
 In this review, we have proposed the novel hypothesis that altered myelination of 
PV+ interneurons might function prominently in the pathophysiology of schizophrenia. 
However, many questions remain to be answered. At what point during development 
does interneuron myelination occur and to what extent does this coincide with 
the clinical symptoms of schizophrenia? Does interneuron myelination vary across 
brain regions? Is cortical interneuron myelination truly reserved for fast-spiking PV+ 
interneurons, or are non-fast-spiking interneurons (e.g., SOM, VIP) myelinated as 
well? How does the plasticity of PV+ interneuron myelination compare to that 
of glutamatergic axons? And perhaps most importantly, to what extent might PV+ 
interneuron myelination represent an etiological pathophysiology and therapeutic 
target for schizophrenia?
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 Future studies to examine the parvalbumin interneuron myelination hypothesis 
could be approached through a variety of methods. In particular, the most important 
experiments would include: a) detailed histological assessment of subtype-specific 
interneuron axonal myelination in post mortem brain tissue from patients with 
schizophrenia, b) corresponding functional studies in rodent models of schizophrenia 
to directly assess the causality of alterations in myelination on behavioral and 
electrophysiological phenotypes, c) electrophysiological studies of rodent models 
with temporally and spatially-restricted disruption of myelination, and d) functional 
genomic studies on the effect of schizophrenia risk variants on (interneuron) 
myelination, for example by utilizing human induced pluripotent stem cells (iPSCs) 
and genetically-modified mice.
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Abstract
 Myelination, the insulating ensheathment of axons by oligodendrocytes, is thought 
to both optimize signal propagation and provide metabolic support. Despite the well-
established physiological importance of myelination to neuronal function, relatively 
little is known about the myelination of GABAergic interneurons in the cerebral 
cortex. Here, we report that a large fraction of myelin in mouse cerebral cortex 
ensheaths GABAergic interneurons, reaching up to 80% in hippocampal subregions. 
Moreover, we find that a very high proportion of neocortical and hippocampal 
parvalbumin (PV) interneurons exhibit axonal myelination. Using a combination of 
intracellular recordings and biocytin labeling of ex vivo human neocortex, we also 
confirm that axons of fast-spiking PV+ interneurons are extensively myelinated in 
the human brain. PV+ interneuron myelination in both mice and humans exhibits 
a stereotyped topography with a bias towards proximal axonal segments and 
relatively short internodes (~27 µm) interspersed with branch points. Interestingly, 
myelin-deficient Shiverer mice exhibit an increased density and more proximal 
location of en-passant boutons, suggesting that myelination might function in part 
to regulate synapse formation along PV+ interneuron axons. Taken together, fast-
spiking interneuron myelination is likely to have broad implications for cerebral 
cortex function in health and disease.
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Introduction
Myelination is the insulating ensheathment of axons by oligodendrocytes, 
demonstrated to optimize action potential propagation and metabolic demands.9,36,38 
Axonal myelination has recently been shown to be modulated by neuronal activity208 
and social experience209,210, and impaired in several psychiatric disorders including 
schizophrenia, bipolar disorder, and autism spectrum disorder.211–214
 In the cerebral cortex, the myelination of pyramidal neurons has been extensively 
investigated215, but comparatively little is known about myelination of GABAergic 
interneurons. Several studies have reported myelination of local GABAergic 
interneurons throughout the brain.160,216,217 However, the ubiquity of cerebral cortex 
parvalbumin-positive (PV+) interneuron myelination remains largely unexplored in 
mice, and has rarely been investigated in humans. GABAergic interneurons exert a 
powerful modulation on local cerebral cortex network activity and brain oscillations. 
In particular, the fast-spiking, PV+ subclass of interneurons function crucially in 
governing feedforward and feedback inhibition in cortical microcircuits, as well 
as tightly regulating fast network oscillations.47 Dysfunction of PV+ interneuron 
function has been strongly linked to multiple psychiatric disorders.53
 In the current study, we examined the myelination of GABAergic interneurons in 
the cerebral cortex of mice and humans. Using cell-type specific fluorescent reporter 
lines, we found that a substantial fraction of myelin in the cortex and hippocampus 
belongs to GABAergic interneurons, in particular fast-spiking PV+ interneurons. 
Using viral labeling, the vast majority of PV+ interneurons we examined in the cortex 
and hippocampus exhibited myelinated axons. Furthermore, we independently 
replicated this finding in both mouse and human cerebral cortex using intracellular 
biocytin labeling during patch-clamp recordings followed by axonal reconstructions. 
PV+ interneuron myelination exhibited a topography biased towards proximal axonal 
segments interspersed by unmyelinated branch points. Local axonal morphology 
was correlated with myelination status, in which inter-branch point distances were 
shorter when the corresponding axonal segment was unmyelinated. Additionally, 
myelin-deficient Shiverer mice exhibited an increased density of proximal en-passant 
boutons, suggesting that myelination functions to regulate the axonal morphology of 
PV+ interneurons in the cerebral cortex.
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Results
A substantial fraction of cerebral cortex myelin ensheaths PV+ 
interneurons
 To examine the extent to which GABAergic axons are myelinated in the mouse 
brain, we utilized the Ai14 cre-dependent fluorescence reporter strain in combination 
with cre driver lines for either parvalbumin (PV) or somatostatin (SOM) interneuron 
subclasses, or broadly among GABAergic interneurons (Glutamate Decarboxylase 
2; GAD65; GAD2). Specifically, we quantified axonal co-localization between the 
interneuron subclass-specific expression of tdTomato (Ai14) and myelin basic 
protein (MBP) in the medial prefrontal cortex (mPFC), primary somatosensory 
cortex (S1), and hippocampal CA1 subregion (CA1) using confocal microscopy 
(Fig. 3.1a-c, Supplementary Fig. 3.1) and structured illumination microscopy (SIM; 
Supplementary Fig. 3.2). We observed a systematic gradient of overall myelination 
across cell layers (Fig. 3.1d; all regions P < 0.001), but importantly without variability 
of internode density across cre driver lines (P = 0.101). Similar to the recent finding 
of Micheva et al.216, a sizeable fraction of S1 myelination was attributable to PV+ axons 
(32.6% in S1 layer II-III) with only a minimal contribution of SOM+ axons or other 
GAD65+ interneuron subclasses (Fig. 3.1e). The contribution of PV+ interneuron 
myelination varied across brain regions (P = 0.005), for which the hippocampal CA1 
contribution was significantly higher (76.9% in stratum pyramidale) and the mPFC 
significantly lower (10.1% in layer VI) than in S1 (32.6% in layer II/III). Together, these 
data confirm that a substantial fraction of cerebral cortex myelin is contributed by 
PV+ interneurons, albeit with regional variation.
Figure 3.1. Interneuron myelination is cell-type and region-dependent. (a) Representative low magnification images 
of PV::cre;Ai14 (red), MBP (green) and DAPI (blue) in the medial prefrontal cortex (mPFC), somatosensory cortex (S1) 
and hippocampal dorsal CA1 region (CA1). Cell layers are annotated in the DAPI channel. Scale bars for mPFC, S1 and 
CA1 are 80 μm, 80 μm, and 30 μm, respectively. (b) Representative confocal co-localization (arrowheads) between 
tdTomato (red) and MBP (green) in each respective brain region. Scale bars are 5 μm. (c) Representative co-localization 
between tdTomato+ axon (red) and MBP (green), demonstrating a myelinated axonal segment. Scale bar, 5 μm. (d) 
MBP+ internode density varied significantly across cell layers in each brain region examined (P < 0.001 for mPFC, 
S1 and CA1; one-way analyses of variance). In contrast, as expected there were no differences in internode density 
between PV::cre;Ai14, SOM::cre;Ai14, and GAD2::cre;Ai14 reporter lines (repeated measures analysis of variance, 
Region x Genotype interaction, P = 0.101). (e) Co localization of PV::cre;Ai14, SOM::cre;Ai14, and GAD2::cre;Ai14 
with MBP across cell layers and between regions. Interneuron myelination exhibited a significant Region * Genotype 
interaction (P = 0.002), with main effects of both Region (P = 0.005) and Genotype (P = 0.010). Post hoc Tukey’s test 
revealed significant differences between PV and SOM myelination in S1 (P < 0.001) and CA1 (P = 0.002), but not 
mPFC (P = 0.722). n = 3 mice per genotype per region. Alv Alveus; SO Stratum oriens; SP Stratum pyramidale; SR 
Stratum radiatum; SLM Stratum lacunosum-moleculare.
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A high proportion of PV+ interneurons exhibit myelinated axons
 We next asked whether cortical PV+ interneuron myelination is limited to a 
subset of cells or is more broadly distributed. Sparse labeling of PV+ interneurons 
was performed using the PV::cre driver line in combination with stereotactic 
injections of reduced-titer rAAV5/EF1a-DIO-mCherry virus into mPFC, S1, or CA1 
(Fig. 3.2a). Axons originating from PV+ somata randomly sampled across different 
layers (n = 144; Fig. 3.2a,b) were examined for MBP immunofluorescence (Fig. 3.2d). 
Of the 144 PV+ interneurons examined, 141 (97.9%) exhibited axonal myelination 
(Fig. 3.2c). This suggests that cerebral cortex PV+ interneurons are frequently 
myelinated, independent of cell layer or brain region.
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Figure 3.2. PV+ interneurons frequently exhibit axonal myelination. (a) PV::cre mice were injected with rAAV5/
Ef1a-DIO-mCherry virus for PV-specific labeling, and sacrificed four weeks later. Low-magnification confocal images 
of PV::cre mice (representative images of n = 7 mice) with virally-labelled PV+ cells (mCherry; red) in mPFC, S1 and 
hippocampal CA1. DAPI (blue) is shown for orientation. Scale bars, 100 μm. (b) Representative co-localization between 
mCherry (red) and PV (green) in S1. Scale bar, 10 μm. (c) The overwhelming majority of PV+ cells in the cerebral 
cortex have myelinated axons. (d) Representative co-localization between an mCherry-filled axon (red) and MBP 
(green), demonstrating a myelinated axonal segment. Scale bar, 5 μm.
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Fast-spiking PV+ cells exhibit region-dependent proximal 
myelination
 Next, we addressed the topography of PV+ axonal myelination in order to examine 
whether internodes are spatially biased along PV+ axons or randomly distributed. 
We performed whole-cell electrophysiological recordings and intracellular 
biocytin-labeling of fast-spiking interneurons (n = 31; Supplementary Fig. 3.3a,b; 
Supplementary Table 3.1) with post hoc morphological reconstruction and PV/MBP 
immunofluorescence labeling in mPFC, S1, and CA1 (Fig. 3.3a,b). Consistent with the 
results obtained with sparse viral labeling, we found that 30 of the 31 reconstructed 
fast-spiking PV+ cells exhibited myelination (total: 96.8%; mPFC: 10/11 cells [90.9%], 
S1: 11/11 cells [100%], CA1: 9/9 cells [100%]; Fig. 3.3c,d). Notably, PV+ interneurons 
were myelinated irrespective of whether their axons originated from the soma or 
primary dendrite.
 Reconstruction of biocytin-labeled cells allowed for classification by axonal and 
dendritic morphology (Supplementary Fig. 3.4a,b). In mPFC, 11 out of 11 PV+ cells 
were morphologically identified as basket cells (100%). Of the 11 reconstructed 
cells in S1, seven cells had a basket cell morphology (63.6%), one had a basket cell 
morphology with large horizontally extending axons and dendrites (horizontally-
elongated cell;43 9.1%), and three had a shrub cell morphology43 (27.3%). In CA1, 
we found three distinct morphological subtypes of PV+ cells: four of the nine 
reconstructed cells had a bistratified morphology with an axon predominantly 
innervating stratum oriens and radiatum (44.4%), while another four cells had a 
perisomatic morphology primarily innervating the pyramidal cell layer (44.4%). 
The final cell had chandelier morphology (11.1%), with distinct axo-axonic bouton 
cartridges originating in stratum oriens and directed orthogonally towards the 
pyramidal cell layer. These findings suggest that PV+ interneuron myelination extends 
beyond the classical basket cell to include a variety of morphological subtypes.
 Detailed axonal reconstructions including myelination (Fig. 3.3c,d; Supplementary 
Fig. 3.4c, Supplementary Fig. 3.5) revealed that PV+ interneuron myelination was 
disproportionately located on proximal axonal segments. The proximal beginning of 
the first internode was found an average distance of 31.4 μm from the origin of the 
axon (mPFC: 31.1 ± 2.1 µm; S1: 27.2 ± 1.9 µm; CA1: 38.1 ± 4.4 µm), and typically 
occurred before the first axonal branch point (mPFC: 81.8%; S1: 90.9%; CA1: 56.6%) 
located at an average distance of 49.8 µm from the soma (mPFC: 45.7 ± 4.4 µm; S1: 
48.8 ± 4.8 µm; CA1: 56.2 ± 8.0 µm). One cell in the mPFC had an atypical topography 
of myelination, in which no internodes were found until immediately distal to the 
secondary axonal branch points (Supplementary Fig. 3.6). Overall, internodes of PV+ 
interneurons had an average length of 27.2 μm, which varied significantly between 
regions (mPFC: 23.3 ± 1.5 µm, n = 54 internodes; S1: 26.0 ± 1.1 µm, n = 141; CA1: 
33.7 ± 2.4 µm, n = 44; P = 0.008), with similarly right-skewed distributions (Fig. 
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Figure 3.3. Topography and regional variation of PV+ interneuron myelination. (a) Maximum projection confocal 
images of representative biocytin-filled PV+ cells (red) with a corresponding fast-spiking AP train in mPFC (left), 
S1 (center) and CA1 (right). Scale bars for electrophysiological traces are 20 mV, 100 ms, and 100 pA from top to 
bottom, respectively. (b) High-resolution SIM co-localization between a biocytin-labelled axon (red) and MBP (green), 
demonstrating a myelinated axonal segment. Scale bar, 10 μm. (c) Partial reconstructions of representative PV+ cells 
in mPFC, S1 and CA1. Soma and axon are shown in grey, and myelinated internodes are shown in green. Note the 
proximal onset and interspersed branch points between internodes. Dendrites have been removed to facilitate axonal 
visualization. Note the dendrite-originating axon in the right panel. (d) Axonal dendrograms showing the schematic 
myelin localization for each cell in (c). Axon in grey, myelin in green. Horizontal axis, μm. (e) Histogram of internode 
length per region (mPFC: n = 54 internodes, 10 cells; S1: n = 141 internodes, 11 cells; CA1: n = 44 internodes, 9 cells). 
(f) Regional characteristics of PV+ axonal myelination. P-values are based on a one-way analysis of variance.
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3.3e). The mean total identified length of axonal myelination was 332.2 μm per cell, 
which varied significantly across brain regions (mPFC: 161.5 ± 27.2 μm; S1: 439.7 ± 
69.1 µm; CA1: 397.9 ± 45.8 µm; P = 0.002, Fig. 3.3f). On average, we identified ~12 
internodes per cell (mPFC: 6.6 ± 0.7 internodes per cell; S1: 14.7 ± 2.2 internodes 
per cell; CA1: 13.0 ± 1.6 internodes per cell). Similar to earlier findings218, we almost 
never observed myelination of branch points (Supplementary Fig. 3.3c).
 To confirm whether myelin integrity may have been compromised during the 
whole-cell patch-clamp tissue preparation, we compared internodes from the in vivo 
viral labeling experiments (Fig. 3.2) with those obtained from the reconstructions 
following intracellular biocytin labeling (Fig. 3.3). No differences in any region 
were observed between methods (Supplementary Table 3.2), thereby providing 
an independent replication of the results and a validation of the two distinct 
methodologies for quantifying internodal segments.
PV+ axons are frequently myelinated in the human brain
 Next, we examined whether myelination of fast-spiking PV+ interneurons 
extends to humans. Ex vivo whole-cell patch clamp recording and intracellular 
biocytin labeling was performed in acutely resected neocortex obtained from 
patients undergoing surgery for subcortical tumors (n = 13 cells, 3 donors; Fig. 3.4). 
Interneurons were readily categorized as fast-spiking (n = 10) or non-fast-spiking 
(n = 3) based on their electrophysiological profile (Fig. 3.4a,b; Supplementary Table 
3.3). Human fast-spiking interneurons exhibited two distinct electrophysiological 
characteristics not observed in mouse – pronounced sag at hyperpolarizing levels 
and near-threshold ‘humps’, both of which have been previously reported in ex vivo 
recordings from acute non-human primate tissue.219-220  
 All of the human fast-spiking interneurons we examined (10/10 cells; 100%), but 
none of the non-fast-spiking cells (0/3 cells), exhibited myelinated axons (P = 0.003; 
Fig. 3.4e-g). Notably, eight of the 10 fast-spiking cells (80%) but none of the non-
fast-spiking cells (0/3 cells; 0%) were PV+ (P = 0.035; Fig. 3.4c,d). Among the eight 
fast-spiking PV+ cells, all had a basket cell morphology.  The two fast-spiking PV– 
cells included a basket cell and a double-bouquet cell. Although the absence of PV 
labeling in these two fast-spiking cells could have resulted from washout during 
whole cell recordings, it is notable that a small subset of fast-spiking cells in the 
mouse neocortex has recently been confirmed to lack PV expression, in particular 
double-bouquet cells.43 Moreover, a subset of basket cells in the neocortex of non-
human primates has also been demonstrated to lack PV expression.220
 Similar to our findings in mice, fast-spiking interneuron myelination in the human 
neocortex was biased towards proximal axonal segments, beginning on average at 
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Figure 3.4. Fast-spiking PV+ interneurons are frequently myelinated in human brain. (a,b) Maximum projection 
confocal images of (a) non-fast-spiking and (b) fast-spiking biocytin-filled cells (red) from resected human surgical 
tissue. Scale bars, 15 μm. Representative voltage responses to depolarizing and hyperpolarizing current injections. 
Fast-spiking cells exhibited a typical suprathreshold high frequency non-adapting firing pattern. (c,d) Biocytin-labelled 
cells (red) were classified as PV– (c) or PV+ (d) on the basis of the absence or presence of co-localization with PV 
(blue). Scale bars, 20 μm. (e) Representative co-localization between biocytin-filled axons (red) and MBP (green), 
showing a myelinated axonal segment. Scale bar, 5 μm. (f) Representative examples of partially reconstructed PV+ 
interneurons.  Soma and axon are shown in grey, and myelinated internodes are shown in green. Note the proximal 
onset and interspersed branch points between internodes. Dendrites were removed from the left and right panels 
to facilitate axonal visualization. Note the dendrite-originating axon in the middle panel. Corresponding fast-spiking 
electrophysiological profiles are shown directly below each morphological reconstruction. (g) Characteristics of human 
fast-spiking interneuron axonal myelination. FS, fast-spiking. (h) Histogram of internode lengths (n = 194 internodes, 
10 cells). Scale bars for electrophysiological traces in a, b and f are 20 mV, 100 pA and 100 ms from top to bottom, 
respectively.
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26.5 ± 1.4 µm from the soma (Fig. 3.4f,g; Supplementary Fig. 3.7) and most commonly 
occurring before the first branch point (80%) located 47.9 ± 8.2 μm from the soma. 
Internodes had an average length of 33.0 ± 1.4 µm (n = 194; Fig. 3.4h). The total 
length of identified axonal myelination per cell was 1035.3 ± 264.4 μm, which was 
notably longer than we observed in mice. On average, we identified 31.6 ± 2.5 
internodes per human fast-spiking interneuron. Together, these data suggest that 
myelination of neocortical fast-spiking interneurons is a conserved feature of both 
the mouse and human brain.
PV+ axonal branch morphology predicts segmental myelination
 Internodes along PV+ axons often ensheathed the full distance between branch 
points. However, inter-branch segments were frequently unmyelinated, particular 
those of shorter distance (Fig. 3.3c,d). Given the relatively small proportion of 
internodes <10 µm (Fig. 3.3e), we hypothesized that segmental myelination status 
might be correlated with inter-branch distance. To examine this directly, we quantified 
inter-branch point distances up to fifth-order axonal segments and whether each 
of these segments contained an internode (Fig. 3.5a). In line with our hypothesis, 
we found that unmyelinated inter-branch point segments were consistently shorter 
than corresponding myelinated segments (P < 0.001 for mPFC, S1, and CA1; Fig. 
3.5b). Overall, the majority of inter-branch segments ≥15 µm showed myelination 
(66.7%), while inter-branch segments <15 µm tended to be unmyelinated (90.8%). 
An analogous dichotomy was evident also in the location of the first axonal branch 
point, which was located closer to the soma when it arose before, compared to 
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Figure 3.5. Axonal morphology predicts segmental myelination. (a) Representative PV+ interneuron reconstruction 
(top) from S1, along with its axonal dendrogram (bottom) with myelinated segments shown in green. Horizontal 
axis, μm. (b) Quantification of inter-branch point distances (2nd to 5th-order axonal branches) for myelinated versus 
unmyelinated segments in mPFC (left), S1 (middle), and CA1 (right). Myelinated axonal segments (blue) are significantly 
longer than unmyelinated segments (red) in all three regions. n = 4 cells per region. *** P < 0.001; Unpaired two-tailed 
Student’s t-test.
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after, the first internode (P = 0.010). Together, this suggests that the likelihood of 
segmental myelination might be governed by spatial limitations imposed by axonal 
morphology.
Myelination regulates the density of PV+ axonal en passant 
boutons
 We observed that the most proximal en passant boutons were frequently 
positioned just a short distance beyond the distal end of myelination. Moreover, 
the one unmyelinated mPFC basket cell that we identified previously using confocal 
imaging showed a higher density and proximally shifted topography of en passant 
boutons (Supplementary Fig. 3.8). Consequently, we hypothesized that en passant 
bouton formation might be constrained by myelination. To examine this possibility 
directly, we quantified the density of proximal en passant boutons along PV+ 
interneuron axons in mPFC of myelin-deficient Shiverer mice (Fig. 3.6a, Supplementary 
Fig. 3.9). Using intracellular biocytin-labeling of fast-spiking PV+ interneurons and 
SIM (Fig. 3.6b,c), we observed a more proximal onset (P < 0.001; Shiverer: 47.4 ± 
5.7 μm from soma; WT: 111.1 μm ± 7.7 from soma; Fig. 3.6d) and higher density 
(P = 0.013; Shiverer: 3.3 ± 0.7 boutons per 100 μm; WT: 0.7 ± 0.5 boutons per 100 
µm; Fig. 3.6e) of en passant boutons in the absence of myelination. However, axonal 
length was unchanged (P = 0.827; Shiverer: 137.8 ± 6.9 μm; WT: 139.9 ± 5.5 μm; Fig. 
3.6f). Together, these findings suggest that myelination regulates the density of PV+ 
axonal en passant boutons and offer additional support for a broad inter-relationship 
between axonal morphology and myelination.
Discussion
 In the present paper, we report that a substantial fraction of myelin in the cerebral 
cortex ensheaths axons of GABAergic interneurons, a finding predominately 
attributable to the fast-spiking PV+ subclass of interneurons. Moreover, utilizing 
two independent methodologies, we find that a high proportion of fast-spiking PV+ 
interneurons in mouse cerebral cortex exhibit axonal myelination. In addition, using 
ex vivo whole-cell recordings and intracellular biocytin labeling of human neocortex, 
we confirm that fast-spiking PV+ cells in the human brain are also frequently 
myelinated. PV+ interneuron myelination most commonly involves the proximal 
axon, consists of small internodes interspersed by axonal branch points, and occurs 
predominantly on longer inter-branch segments. Finally, and suggestive of a causal 
functional influence of myelination on PV+ axonal morphology, we find that myelin-
deficient Shiverer mice exhibit an increased density and ectopic localization of en-
passant boutons.
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Figure 3.6. Altered PV+ axon morphology in myelin-deficient Shiverer mice. (a) Mid-sagittal section from Shiverer 
mice (Shiv) demonstrates the absence of MBP expression, whereas WT mice show extensive myelination (green). Scale 
bar, 1 mm. (b) Maximum projection confocal images of representative biocytin-filled PV+ cells (red) from the mPFC 
with a corresponding fast-spiking AP train in WT (left) and Shiverer (right) mice. Scale bars are 20 mV, 100 ms, and 100 
pA from top to bottom, respectively. (c) High-resolution SIM images of biocytin-labelled axons, centered on the third 
branch order, showing morphological evidence of en passant boutons (arrowheads) in WT (left) and Shiverer (right). 
Scale bar, 10 μm. (d) Shiverer mice (blue) have a significantly more proximal bouton onset, and (e) higher number of 
boutons on the proximal axon compared to WT mice (black). (f) Cumulative axonal length (through 3rd order axon 
branches) is unchanged (P = 0.827). Shiverer: n = 10 cells; WT: n = 7 cells. Bars represent means ± s.e.m. ***P < 0.001; 
*P = 0.013; Unpaired two-tailed Student’s t-test.
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 A recent study216 reported a large contribution of GABAergic interneurons to 
the total myelin content of primary somatosensory cortex using array tomography 
and scanning electron microscopy. Our findings considerably extend these results 
by demonstrating that the contribution of GABAergic interneuron myelination 
is region-dependent, with the mPFC exhibiting a lower, and the hippocampus a 
higher, relative fraction of interneuron myelination. In the CA1 subregion of the 
hippocampus, nearly 80% of myelin in stratum pyramidale and radiatum originates 
from GABAergic interneurons, which is contributed almost exclusively by PV+ 
interneurons. This finding could suggest a particularly important contribution 
of interneuron myelination in hippocampal function. Alternatively, the high 
proportion of myelin contributed by GABAergic interneurons may simply reflect 
the limited myelination of CA1 pyramidal neurons. Regardless, in light of the 
predominant contribution of interneuron myelination to the total myelin content 
of the hippocampus, experience-dependent or neuropathological alterations of 
hippocampal myelination are likely to involve PV+ interneurons. Conversely, the 
relatively lower contribution of interneuron myelination in the prefrontal versus 
somatosensory cortex is at least in part, if not entirely, due to a more limited extent 
of myelination per PV+ interneuron. Notably however, our analysis was performed 
entirely during early adulthood for which it remains unknown whether the relative 
contribution of cerebral cortex interneuron myelination is neurodevelopmentally 
regulated.
 In addition to PV+ interneuron myelination, we also find a small, but consistent, 
contribution of cortical myelin arising from axons of SOM+ interneurons. The 
contribution of SOM+ interneuron myelination is similar in mPFC and S1, but 
somewhat higher in CA1 consistent with the limited myelination of hippocampal 
principle cells.5 SOM+ interneurons are a heterogeneous group of GABAergic cells 
with relatively lower firing rates than PV+ interneurons.221 A precise quantification 
of the proportion of SOM+ interneurons that are myelinated, and whether they 
exhibit a similarly biased topography of proximal myelination as PV+ cells, remains 
to be determined.
 Although the majority of our PV+ interneuron reconstructions exhibited a 
basket cell morphology, we also recovered fast-spiking PV+ bistratified, shrub, and 
chandelier cells in the CA1 subregion of the hippocampus, all of which had myelinated 
axons. Although these observations require further replication to be considered 
conclusive, they nevertheless suggest that PV+ interneuron myelination is likely to 
extend beyond the classical basket cell subtype. Moreover, they also highlight the 
question of whether each PV+ interneuron subtype has a unique topography and 
function of axonal myelination.
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 Using axonal reconstructions, we find that PV+ interneuron myelination has a 
spatially-biased topography with internodes occurring predominantly on axonal 
segments of low branch order. In particular, the first internode is typically positioned 
~30 µm from the soma, directly following the location of action potential initiation 
(~25 µm from the soma) within the axon initial segment.222,223 Interestingly, none 
of the cells showed exceptionally long distances to myelin onset (>60 µm), as has 
recently been shown for a subset of S1 pyramidal cells.215 In most instances, the 
first axonal branch point occurs immediately following the first internode at ~45 
µm from the soma. This stereotyped sequence of axon initial segment – internode 
– branch point raises the question of whether the first internode and branch point 
function to modulate action potential generation in PV+ interneurons, as has been 
previously suggested for cerebellar Purkinje cells224 and S1 layer V pyramidal cells.225 
 Low-order axonal branches of PV+ interneurons contain myelinated and 
unmyelinated segments interspersed with branch points. Notably, we observed a 
correlation between the inter-branch distance and the probability of that segment 
being myelinated, in which axonal segments connecting branch points in close 
proximity were less likely to contain internodes. Given that the observed minimum 
internode length is ~10 µm, there appears to be a critical threshold distance of 
uninterrupted axon required for an internode to be stably established, beyond which 
shorter axonal segments remain unmyelinated. Notably, this mechanism could also 
account for the high proportion of PV+ interneurons that have their first internode 
located proximal to the first axonal branch point. 
 The functional significance of cerebral cortex interneuron myelination remains at 
present largely unknown. Considering that mouse cerebral cortex PV+ interneurons 
exhibit a total axonal length of ~20 to 30 mm47 (see also Supplementary Fig 3.4c), 
only ~1-2% of the total axonal length is myelinated. Notably however, the proximally 
biased distribution of internodes along PV+ interneuron axons observed consistently 
in both mouse and human might be an efficient mechanism to ensure that a high 
proportion of APs pass through myelinated segments, thereby potentially enhancing 
conduction velocity, fidelity and metabolic support. In addition, the most distally 
located internodes were nearly always followed by morphological evidence of en-
passant boutons, raising the question of whether myelination is functionally related to 
the establishment and/or maintenance of boutons. Therefore, we examined myelin-
deficient Shiverer mice and indeed found that in the absence of myelin, the proximal 
axon exhibited a higher density and proximally ectopic localization of en-passant 
boutons. Accordingly, PV+ interneuron axonal myelination might function in part to 
inhibit synapse formation along the proximal axon. By limiting synapse formation 
on the proximal axon, myelination could facilitate PV+ interneurons in achieving 
synchronous inhibition of their postsynaptic targets, given that en passant boutons 
have been suggested to attenuate axonal conduction velocity.223 Therefore, in 
addition to facilitating action potential propagation through the classical mechanisms 
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mediated by increased axonal diameter and membrane resistance, myelin may also 
function to enhance conduction velocity by limiting synapse formation along the 
proximal axon.
 Compared to glutamatergic pyramidal neurons, the relatively short conduction 
delays observed in PV+ interneurons are thought to result from their faster membrane 
time constant, lower AP threshold, and small aspiny dendritic morphology.47,226–230 
Moreover, PV+ interneurons are highly energy demanding205, for which myelin 
provides axonal metabolic support.36–38 However, more distal myelination of PV+ 
interneurons might be limited by the apparently strict biophysical threshold of a 
minimum caliber (~300 nm) for oligodendrocytes to successfully ensheath axonal 
segments. Spatially-restricted proximal myelination of fast-spiking PV+ interneurons 
might therefore be an efficient mechanism to enhance conduction velocity, AP fidelity 
and metabolic support, while also limiting the formation of lower conductivity 
en passant synapses, together in the service of coordinating rapid, temporally-
synchronous GABA release across the entire axonal tree.
 An interesting outstanding question is whether direct synaptic contacts from 
PV+ interneurons onto oligodendrocyte precursor cells regulate interneuron 
myelination194, and how their intercellular interactions during early waves of neural 
migration might shape interneuron myelination.231 Especially interesting is the possible 
relevance of how the distance-dependence of the contact between oligodendrocyte 
progenitor cells and PV+ interneurons194 might be related to the proximally-biased 
topography of PV+ interneuron myelination. Moreover, the recent demonstration 
of a wide diversity of myelinating oligodendrocyte subtypes classified by single-
cell RNA sequencing raises the question of whether individual oligodendrocytes 
have constraints in the repertoire of neuronal cell types that they are capable of 
ensheathing.232 Furthermore, recent studies demonstrating that axonal myelination 
of pyramidal neurons is highly dynamic and experience-dependent208 also raise the 
question of the extent to which interneuron myelination has similar, or perhaps 
distinct, mechanisms of developmental and experience-dependent plasticity.
 Using acute surgically resected tissue, we also confirmed that interneuron 
myelination extends to the human neocortex, with quantitative parameters largely 
similar to mouse neocortex. This is particularly notable given that our findings might 
have been influenced by factors not present in rodent studies, such as advanced age, 
confounding by surgical indication, or medication. Given the putative role of both 
GABAergic interneurons and myelination in disorders of the brain, the confirmation 
of PV+ interneuron myelination in the human neocortex provides additional support 
for its potential pathophysiological relevance.
 In summary, we find that PV+ interneurons in the mouse and human cerebral 
cortex are frequently myelinated.  Internodes along PV+ interneuron axons have 
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a spatially-biased proximal topography, are correlated with axonal morphology, 
and exhibit quantitative differences between cortical subregions. Moreover, we 
demonstrate that in the absence of myelin, PV+ interneurons acquire a higher 
density and ectopic localization of en passant boutons. Together, these findings 
suggest that myelination is an important feature governing the function of cerebral 
cortex interneurons.
Methods
Mice
 All experiments were approved by the Dutch Ethical Committee and in 
accordance with the Institutional Animal Care and Use Committee (IACUC) 
guidelines. All mouse lines were obtained from Jackson Laboratory:  
 Pvalbtm1(cre)Arbr/J mice (PV::cre)233  strain #008069
 Ssttm2.1(cre)Zjh/J (SOM::cre)234  strain #013044
 Gad2tm2(cre)Zjh/J (GAD2::cre)235  strain #010802
 Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/J (Ai14)235  strain #007908
 B6;C3Fe.SWV-Mbpshi/J (Shiverer)236  strain #001428
 C57BL/6J (WT) strain #000664
All lines were backcrossed for more than 10 generations in C57BL/6J. Lines 
were crossed to obtain heterozygous PV::cre x heterozygous Ai14 (PV::cre;Ai14), 
SOM::cre x Ai14 (SOM::cre;Ai14) and GAD2::cre x Ai14 mice (GAD2::cre;Ai14). 
Heterozygous B6;C3Fe.SWV-Mbpshi mice were crossed to obtain homozygous 
and heterozygous Shiverer mice and wildtype littermates. For global myelination 
quantifications and viral labeling, mice were used from 8 to 12 weeks of age. For 
electrophysiological recordings, mice were used from 5 to 8 weeks of age. Mice 
were group-housed and maintained on a 12 h light/dark cycle with ad libitum access 
to food and water. All experiments were approved by the Dutch Ethical Committee 
and in accordance with the Institutional Animal Care and Use Committee (IACUC) 
guidelines.
Human Brain Tissue
 Neocortical tissue was obtained from 3 patients undergoing tumor resection 
surgery at the Department of Neurosurgery (Erasmus University Medical Center, 
Rotterdam, The Netherlands). All procedures regarding human tissue were 
performed with the approval of the Medical Ethical Committee of the Erasmus 
University Medical Center. Written informed consent of each patient was provided 
in accordance with the Helsinki Declaration.
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 Patient #1 was a 54-year old female presenting with a WHO grade 4 glioblastoma 
in the right temporo-occipital lobe. She had no significant psychiatric or past medical 
history, and no history of epilepsy or seizures. Patient received no anti-epileptic or 
cytostatic medication.
 Patient #2 was a 69-year old male presenting with a hemangiopericytoma/solitary 
fibrous tumor on the posterior border of the left ventricle. He had no significant 
psychiatric or past medical history, and no history of epilepsy or seizures. Patient 
received no anti-epileptic or cytostatic medication.
 Patient #3 was a 59-year old male presenting with a WHO grade 4 glioblastoma in 
the right temporal lobe. His psychiatric history was notably only for a single episode 
of depression which fully remitted. He had no history of epilepsy, but experienced a 
single tonic-clonic seizure 3 weeks prior to surgery, for which he was treated with 
sodium valproate (1000 mg daily). Patient received no cytostatic medication.
Mouse Viral Labeling
 Heterozygous PV::cre mice were used for viral-mediated cell-type specific 
labelling, which was performed using cre-dependent adeno-associated virus (AAV) 
expression with AAV5/EF1a-DIO-mCherry or AAV5/Flex-eGFP (University of 
Pennsylvania Viral Vector Core). Virus was diluted to ~5 x 1011 GC/ml in phosphate-
buffered saline (PBS) to achieve sparse labelling.
 Anesthesia was induced using 5% isoflurane, and subsequently maintained 
with 2% isoflurane during surgery. Body temperature was maintained at 37°C. 
Bupivacaine hydrochloride (2.5 mg/ml), Rimadyl (50 mg/ml), and Temgesic (0.3 mg/
ml) were administered subcutaneously. Mice were placed into the stereotaxic frame 
(Stoelting) using stub ear bars for head fixation. Longitudinal scalp incision of 1-2 cm 
length was made to reveal the skull, and a craniotomy was performed overlying the 
site of injection at the following coordinates (in mm):
 mPFC:  +2 bregma, 0.5 lateral, 2 vertical 
 S1:  -1 bregma, 2 lateral, 0.5 vertical 
 CA1:  -1.5 bregma, 1 lateral, 1.5 vertical
A borosilicate glass micropipette was slowly lowered to the target site and remained 
in place for 5 min before the start of injection. Virus injection was controlled by 
a manual syringe pump (0.5 µl per location, infusion speed 0.05 µl/min). At the 
conclusion of the injection, the micropipette was maintained in place for another 5 
min and then slowly withdrawn. After surgery, mice were allowed to recover for 3-4 
weeks before analysis.
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Electrophysiology
Mouse Recordings
 Anesthesia was induced using 5% isoflurane and mice were transcardially 
perfused with 20 ml of ice-cold, NMDG-based cutting solution containing (in mM): 
93 N-methyl-d-glucamine (NMDG), 93 HCl, 30 NaHCO3, 25 D-glucose, 20 HEPES, 
5 Na-ascorbate, 2 thiourea, 10 MgCl2, 3 Na-pyruvate, 2.5 KCl, 1.25 NaH2PO4 and 0.5 
CaCl2 (300 mOsm, pH 7.4) oxygenated with 95% O2/5% CO2 before decapitation. 
After decapitation, the brain was quickly dissected in the same ice-cold cutting 
solution. For each brain region examined, coronal slices (300 µm) were cut with 
a vibrating slicer (Microm HM 650V, Thermo Scientific) and incubated in cutting 
solution at 37 °C for 30 seconds, followed by oxygenated (95% O2/5% CO2) artificial 
cerebrospinal fluid (aCSF) at 37 °C for 45 min. ACSF contained (in mM) 127 NaCl, 
25 NaHCO3, 25 D-glucose, 2.5 KCl, 1.25 NaH2PO4, 1.5 MgSO4 and 1.6 CaCl2. 
Slices were then allowed to recover at room temperature for at least 1 h before 
recordings.
 In Shiverer and wildtype mice, interneurons were visualized using infrared 
differential interference contrast microscopy. In PV::cre;Ai14 mice, PV+ interneurons 
were visualized by native tdTomato fluorescence using an RFP filter (Semrock, 
Rochester, NY, USA). Whole-cell recordings were made using borosilicate glass 
pipettes (3.5–5.5 MΩ resistance) with intracellular solution containing (in mM) 120 
K-gluconate, 10 KCl, 10 HEPES, 10 K-phosphocreatine, 4 ATP-Mg, 0.4 GTP, and 5 mg/
ml biocytin (pH was adjusted to 7.4 using KOH, and osmolarity measured 285-290 
mOsm). 
 Recordings were performed in aCSF at near-physiological temperatures (32-
33°C) using HEKA EPC10 quattro amplifiers and Patchmaster software (40 or 200 
kHz sampling rates depending on the total recording length to avoid memory limits 
during acquisition). Series resistance was typically <25 MΩ and fully compensated 
for bridge balance and capacitance; recordings in which the series resistance 
exceeded 25 MΩ were not included in the pooled averages. No correction was 
made for liquid junction potential. Data analysis was performed offline using Igor 
Pro v6 (Wavemetrics).
 Basic physiological characteristics were determined from voltage responses to 
square-wave current pulses of 500 ms duration, ranging from –100 pA to +300 pA, 
and delivered in 20 pA intervals. Input resistance was determined by the slope of 
the linear regression through the voltage-current curve. Single action potential (AP) 
characteristics were obtained from the first elicited action potential. AP threshold was 
defined as the inflection point at the foot of the regenerative upstroke. AP amplitude 
was defined as the voltage difference between the threshold and peak voltage. AP 
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half-width was measured at half of the peak amplitude. AP rise time was quantified 
as duration from 10% to 90% of the peak amplitude. The fast after-hyperpolarizing 
potential (fAHP) was measured as the peak hyperpolarizing deflection following AP 
initiation. AP frequency was determined from a 500 ms square-wave current pulse 
of +300 pA.
Human Recordings
 Ex vivo recordings of human neocortex were performed using tissue requiring 
surgical resection in order to access the location of the tumor. Immediately following 
resection, the neocortical tissue block was directly transferred to oxygenated (95% 
O2/5% CO2) ice-cold cutting solution and transported to the electrophysiology 
laboratory. The time between tissue resection and slicing was always <10 min. Tissue 
slices were used for electrophysiological recordings only when no infiltrating tumor 
cells were detectable in the slice. Whole-cell recordings and electrophysiological 
analyses were performed identically similar to mouse tissue.
 In total, we recorded from 20 cells (patient #1: 4 cells; patient #2: 14 cells; patient 
#3: 4 cells), of which 13 cells (65%; (patient #1: 3 cells; patient #2: 8 cells; patient #3: 
2 cells) were successfully biocytin-filled and reconstructed.
Fluorescence Immunohistochemistry
Mouse Tissue
 Deep anesthesia was induced by intraperitoneal injection of pentobarbital, and 
mice were transcardially perfused with saline followed by 4% paraformaldehyde 
(PFA). Brains were dissected and post-fixed in 4% PFA for 2 h at room temperature. 
Brains were transferred into 10% sucrose phosphate buffer (PB 0.1 M, pH 7.3) and 
stored overnight at 4°C. Embedding was performed in a 12% gelatin/10% sucrose 
block, with fixation in 10% paraformaldehyde/30% sucrose solution (PB 0.1 M, pH 
7.3) for 2 h at room temperature and immersed in 30% sucrose (PB 0.1 M, pH 7.3) 
at 4°C overnight. Forty micrometer coronal and sagittal sections were collected 
serially (rostral to caudal) using a freezing microtome (Leica, Wetzlar, Germany; SM 
2000R) and stored in 0.1 M PB. Free-floating sections were incubated in sodium 
citrate (10 mM) at 80 °C for 30 min and rinsed with PBS (pH 7.3). Sections were 
pre-incubated with a blocking PBS buffer containing 0.5% Triton X-100 and 10% 
normal horse serum (NHS; Invitrogen, Bleiswijk, The Netherlands) for 1 h at room 
temperature. Sections were incubated in a mixture of primary antibodies in PBS 
buffer containing 0.4% Triton X-100 and 2% NHS for 72 h at 4°C. 
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 The following primary antibodies were used: rabbit anti-mCherry (1:500, 
Millipore, Abcam, ab167453), mouse anti-PV (1:1000, Swant, 235), and goat anti-MBP 
(1:300, Santa Cruz, C-16, sc-13914). We additionally confirmed the specificity of 
the anti-MBP antibody using both western blot analysis and immunofluorescence 
labeling in tissue from MBP-deficient Shiverer mice (Supplementary Fig. 3.9).
 For recovery of biocytin-labelled cells following electrophysiological recordings, 
slices were incubated overnight at 4°C in 4% PFA. Slices were then rinsed at room 
temperature in 0.1 M PB, incubated for 12 h at 4°C in 10% sucrose (0.1 M PB), and 
overnight at 4°C in 30% sucrose (0.1 M PB). Sections were serially recut at 40 μm 
using a freezing microtome (Leica, Wetzlar, Germany; SM 2000R) and stored in 0.1M 
PB at 4°C.
 Sections were washed with PBS, and incubated with corresponding Alexa-
conjugated secondary antibodies (1:300, Invitrogen) and cyanine dyes (1:300, Sanbio, 
Uden, The Netherlands) in PBS buffer containing 0.4% Triton X-100, 2% NHS for 
2 h at room temperature. For biocytin-labelled cells, streptavidin-A488 (1:300, 
Jackson) was used. For some experiments, nuclear staining was performed using 
DAPI (1:10.000, Invitrogen). Sections were washed with PB 0.1M and mounted on 
slides, cover slipped with Vectashield H1000 fluorescent mounting medium (Vector 
Labs, Peterborough, UK) and sealed. 
Human Tissue
 Three-hundred μm electrophysiology slices were incubated overnight at 4°C in 
4% PFA. Slices were then rinsed at room temperature in 0.1 M PB, incubated for 12 
h at 4°C in 10% sucrose (0.1 M PB), and overnight at 4°C in 30% sucrose (0.1 M PB). 
Forty μm sections were collected serially using a freezing microtome (Leica, Wetzlar, 
Germany; SM 2000R) and stored in 0.1M PB. Sections were extensively washed 
and pre-incubated with a blocking PBS buffer containing 0.5% Triton X-100 and 
5% bovine serum albumin (BSA; Sigma-Aldrich, The Netherlands) for 1 h at room 
temperature. Next, sections were incubated in a mixture of primary antibodies in 
PBS buffer containing 0.5% Triton X-100 and 1% BSA for 72h at 4°C. The following 
primary antibodies were used: mouse anti-PV (1:1000, Sigma, P3088, clone Parv-19) 
and goat anti-MBP (1:300, Santa Cruz, C-16, sc-13914).
 Sections were extensively washed with PBS (>2 h), and incubated with 
corresponding Alexa-conjugated secondary antibodies (1:300, Invitrogen), cyanine 
dyes (1:300, Sanbio, Uden, The Netherlands) and streptavidin-A488 (1:300, Jackson) 
in PBS buffer containing 0.5% Triton X-100 and 1% BSA for 5 h at room temperature. 
Nuclear staining was performed using DAPI (1:10.000, Invitrogen, Bleiswijk). Sections 
were washed with PB 0.1 M and mounted on slides, cover slipped with Vectashield 
H1000 fluorescent mounting medium (Vector Labs, Peterborough, UK) and sealed.
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Confocal Imaging and Analysis
 Confocal imaging was performed using a Zeiss LSM 700 microscope (Carl Zeiss) 
equipped with Plan-Apochromat 10x/0.45 and 63x/1.4 (oil immersion) objectives. 
Alexa488, Cy3, Alexa647, and Alexa405 or DAPI were imaged using excitation 
wavelengths of 488, 555, 639 and 405nm, respectively.
 Quantification of region-dependent myelination was performed in the prelimbic 
region of the mPFC (bregma: +2.10 till +1.54 mm), somatosensory cortex layers 
(bregma: -0.82 till -1.22 mm) and dorsal hippocampal CA1 (bregma: -1.58 till -1.94 
mm) by obtaining z-stack images (1064 x 1064 pixels) at 63x magnification (1.4 NA; 
oil immersion) with 1x digital zoom at a step size of 1 µm. Stacks were randomly 
sampled across all layers of mPFC, somatosensory cortex and hippocampal CA1 based 
on DAPI nuclear labeling, using a 100 x 100 μm counting frame. Immunofluorescent 
co-localization of MBP and tdTomato was manually-counted by two independent 
raters (J. S. and D. B.) using NIH ImageJ (version 1.41). Co-localization was defined as 
the circumferential bordering of a tdTomato-labelled axon by an MBP+ myelin signal. 
At least three z-stacks were analysed per mouse per region per layer. 
 Analogous to previous reports43,237,238, a small fraction of cells in the SOM::cre;Ai14 
mice (~10%) had expression of PV in medial prefrontal and somatosensory cortex. 
Due to the difficulty in performing axonal triple co-localizations (MBP/SOM/PV), and 
the bona fide endogenous co-expression of PV and SOM in hippocampal bistratified 
and oriens-lacunosum moleculare cells239, we have reported the corresponding 
double co-localizations (MBP/SOM and MBP/PV). The MBP/SOM double co-
localizations reported in Fig. 3.1 therefore likely represent an minor overestimation 
of the actual frequency of SOM+ interneuron axonal myelination.
 For analysis of myelination along virus-labelled PV+ axons, overview images were 
obtained at 10x with 1x digital zoom. Individual labelled cells distributed over layers 
LII-LVI in mPFC and S1, and dorsal hippocampal CA1 stratum oriens, pyramidale and 
radiatum were categorized and examined at 63x with 1x digital zoom to confirm 
labelling with the PV antibody. Confocal z-stack images (2128 x 2128 pixels) were 
obtained at 63x magnification with 1x digital zoom at a step size of 2 μm along the 
full z-axis extent of the section. Axons were identified as the thinnest, smoothest, 
and most highly branched processes originating from either the soma or primary 
dendrite. In addition, axons seemed to branch at more obtuse ≥90° angles from 
one another, often turning back toward the soma, whereas dendrites branched at 
smaller angles (<90°), continuing a trajectory away from the soma. PV+ cells were 
considered to be myelinated when they exhibited at least one myelinated internode. 
If the axon exited the slice before 50 µm, cells were excluded from further analysis. 
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 Axonal reconstructions of mouse and human biocytin-filled cells were obtained 
at 63x magnification (5320 x 5320 pixels) with 1x digital zoom and a step size 
of 0.5 µm. Pixel dwell was kept at >1.5 µs for optimal subsequent co-localization 
identification. Images were transferred to Neurolucida 360 software (v2.6; MBF 
Bioscience) and reconstructed using interactive tracing with the Directional Kernels 
method. Reconstructed soma, axon and myelin segments were analyzed with 
Neurolucida Explorer (MBF Bioscience).
 The distance to first myelin was defined as the distance along the axon from the 
soma, or in the case of dendrite-originating axons the distance from the originating 
dendrite, to the initial point of MBP immunofluorescence. Myelin segments that exited 
a slice were removed from subsequent analysis. Identification and reconstruction of 
axonal myelination was performed blind to electrophysiological (fast-spiking versus 
non-fast-spiking) and cell-type (PV+ versus non-PV) identity. No spatial corrections 
were made for tissue shrinkage. 
Structured Illumination Microscopy (SIM)
 Imaging was performed using a Zeiss Elyra PS1 system. 3D-SIM data was acquired 
using a 63x 1.4NA oil objective. 488, 561 and 642 100mW diode lasers were used 
to excite the fluorophores together with respectively a BP 495-575 + LP 750, BP 
570-650 + LP 75 or LP 655 emission filter. For 3D-SIM imaging, a grating was present 
in the light path, and modulated in 5 phases and 5 rotations, and multiple z-slices 
with an interval of 110 nm were recorded on an Andor iXon DU 885, 1002x1004 
EMCCD camera. Raw images were reconstructed using Zen (Zeiss). 
 For axonal bouton quantifications, SIM images were obtained from proximal 
axons of biocytin-filled cells up till the 3rd branch order. En passant bouton density, 
as well as proximal axonal lengths were quantified using Neurolucida 360 (v2.6; MBF 
Bioscience).
Western Blotting
 Adult homozygous Shiverer mice and WT littermates were anesthetized using 
isoflurane, sacrificed by decapitation, and snap frozen in liquid nitrogen. Protein 
lysates were prepared by homogenization of cortical brain samples in lysis buffer 
(10 mM Tris-HCL pH 6.8, 2.5% SDS, 2 mM EDTA) and adjusted to a concentration 
of 1 mg/ml. Western blots were probed with primary antibodies against MBP (C-16, 
sc-13914, 1:500, Santa Cruz) and beta-actin (MAB1501R, 1:10000, Chemicon), and 
complementary secondary antibodies (goat anti-mouse and donkey anti-goat, 1:5000, 
AffiniPure). Blots were imaged using a LI-COR Odyssey Scanner with Odyssey 3.0 
software.
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Statistical Analysis
 Statistical analysis was performed using IBM SPSS (version 21). Sample sizes were 
chosen based on previous publications utilizing similar methods. Hypothesis testing 
was performed using unpaired two-tailed Student’s t-test or analysis of variance 
(ANOVA) followed by Tukey’s post hoc test. All data are expressed as mean ± 
standard error. Significance threshold was set at P < 0.05. Throughout the paper 
exact P-values values are provided except when P < 0.001.
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SUPPLEMENTARY FIGURE 1
a
b
GAD2::cre;Ai14 MBP
Merge
mPFC S1 CA1
GAD2::cre;Ai14 MBP
Merge
GAD2::cre;Ai14 MBP
Merge
SOM::cre;Ai14 MBP
Merge
SOM::cre;Ai14 MBP
Merge
SOM::cre;Ai14 MBP
Merge
Supplementary Figure 3.1. Cell type-specific interneuron myelination. (a) Representative co-localization 
(arrowheads) between GAD2::cre;Ai14 (red) and MBP (green) in each respective brain region. Scale bars are 5 μm. (b) 
Representative co-localization (arrowheads) between SOM::cre;Ai14 (red) and MBP (green) in each respective brain 
region. Scale bars are 5 μm.
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SUPPLEMENTARY FIGURE 2
PV::cre;Ai14 MBP Merge
Supplementary Figure 3.2. PV+ interneuron myelination. High-resolution maximum projection SIM image 
demonstrating PV::cre;Ai14-labeled axons (red) co-localized with MBP (green) in layer II-III of S1. Scale bar, 1 μm.
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SUPPLEMENTARY FIGURE 3
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Supplementary Figure 3.3. Single-cell reconstructions. (a) Location of biocytin-labeled cells are illustrated with 
black circles in mPFC (n = 11 cells), S1 (n = 11 cells), and hippocampus (n = 9 cells). Coordinates delineate the 
rostrocaudal extent of recorded cells (Paxinos and Franklin 2001). Note that some cells in each region fall outside 
strict regional boundaries. (b) Confocal images of triple co-localizations of biocytin (red), PV::cre;Ai14 (green) and PV 
(grey) in a hippocampal fast-spiking interneuron from CA1 stratum pyramidale. Scale bar, 50 μm. (c) Confocal image of 
co-localization of biocytin (red) and MBP (green), showing an unmyelinated branch point (arrowhead). Scale bar, 2 μm.
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SUPPLEMENTARY FIGURE 4
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Supplementary Figure 3.4. Reconstructions showing representative examples of distinct morphological 
subtypes of fast-spiking PV+ interneurons. (a) Hippocampal CA1 subtypes showing a classical basket cell with its 
axon restricted to pyramidal cell layer (left), a bistratified cell with its axon projecting to both stratum oriens and 
stratum radiatum (middle), and a chandelier cell (right), showing typical perpendicular bouton cartridges. (b) Cortical 
subtypes showing a classic basket cell (left), horizontally-elongated cell (HEC, middle), and shrub cell (right). All subtypes 
exhibited myelination. Soma and dendrite in black, axon in brown. (c) Dendrogram of a full axonal reconstruction from 
a mPFC layer V basket cell, exemplifying total axonal length. Axon in grey. Horizontal axis, μm. SO Stratum oriens; SP 
Stratum pyramidale; SR Stratum radiatum.
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SUPPLEMENTARY FIGURE 5
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Supplementary Figure 3.5. Additional examples of mouse PV+ axonal myelination. (a-c) Reconstructions of 
representative axonal segments from two independent fast-spiking PV+ cells in mPFC (a), S1 (b), and dorsal CA1 
(c). Note the myelinated segments interspersed with axonal branch points, often with relatively shorter intervening 
unmyelinated segments. Branches that lead towards the soma are indicated.
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SUPPLEMENTARY FIGURE 6
100.0
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Supplementary Figure 3.6. Rare example of PV+ interneuron (mPFC) with an onset of myelination beyond 
first-order branches. Occasionally, myelin onset occurs beyond the first branch point, and rarely beyond the second 
branch point, as depicted here. Reconstruction in (a) and dendrogram in (b). Notice the unusual proximal first branch 
point at ~20 μm from the soma. Soma and axon in grey, myelin in green. Horizontal axis, μm.
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SUPPLEMENTARY FIGURE 7
to soma
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Supplementary Figure 3.7. Additional examples of human fast-spiking interneuron axonal myelination. (a) 
Human fast-spiking interneuron with extensive myelination of the primary axon but predominantly unmyelinated 
secondary branches. Note the axonal branching before onset of myelination. (b) Myelinated axons of human fast-
spiking interneuron with large unmyelinated segments (~50-70 μm) in between myelinated segments. Branches leading 
back to the soma are indicated. Soma and axon are shown in grey, and myelinated internodes are shown in green.
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SUPPLEMENTARY FIGURE 8
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Supplementary Figure 3.8. High-resolution maximum projection SIM image of the biocytin-filled axon (red) 
taken from the only unmyelinated PV+ interneuron identified in the experiment shown in Fig. 3.2. Notably, in the 
absence of myelination, en passant boutons are found on the proximal axon (arrowheads). Scale bar, 10 μm.
Supplementary Figure 3.9. Shiverer mice lack all isoforms of MBP. (a) Western blot probed with the MBP 
antibody confirmed the absence of all MBP isoforms (red) in cortical lysates from Shiverer (Shiv) mice. b-actin (green) 
is shown as loading control.
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mPFC n = 11 S1 n = 11 CA1 n = 9
Average s.e. Average s.e. Average s.e.
RMP (mV) -71.87 1.13 -70.49 1.45 -68.66 1.55
Ri (MΩ) 125.44 11.84 93.61 7.75 116.38 13.81
AP Threshold (mV) -36.90 2.94 -37.78 1.65 -40.13 1.70
AP Amplitude (mV) 81.24 2.69 87.32 1.66 98.10 2.85
AP Frequency (Hz) 124.18 9.57 111.82 12.44 90.44 9.72
AP Half Width (ms) 0.37 0.02 0.27 0.01 0.28 0.01
AP Rise Time (ms) 0.19 0.01 0.14 0.00 0.16 0.01
fAHP Amplitude (mV) -21.45 0.85 -20.37 0.75 -18.79 1.33
Supplementary Table 3.1. Passive membrane properties and single AP characteristics of fast-spiking PV+ 
interneurons from mouse mPFC, S1, and CA1. AP frequency was quantified as the mean AP frequency during a 500 
ms, 300 pA square-wave current pulse. AP, action potential. fAHP, fast after-hyperpolarization. Ri, input resistance. RMP, 
resting membrane potential.
Internode Length 
(µm)
Ex vivo 
Biocytin 
Labeling
In vivo 
Viral 
Labeling
Average s.e. Average s.e. P
mPFC 23.3 1.5 22.7 1.9 0.811
S1 26.0 1.1 27.5 4.3 0.627
CA1 33.7 2.4 32.0 4.2 0.733
Supplementary Table 3.2. Methodological comparison of internode length between genetically-encoded viral 
labeling and intracellular biocytin labeling. P-values are based on Student’s t-test.
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Non-Fast-
Spiking
n = 3 Fast-
Spiking
n = 10 P
Average s.e. Average s.e.
RMP (mV) -64.35 4.42 -64.78 2.07 0.923
Ri (MΩ) 238.30 99.19 151.10 20.67 0.187
AP Threshold (mV) -36.70 2.74 -40.30 1.48 0.268
AP Amplitude (mV) 86.80 1.63 92.93 2.67 0.254
AP Frequency (Hz) 54.67 5.82 121.60 12.32 0.015
AP Half Width (ms) 0.73 0.22 0.30 0.01 0.002
AP Rise Time (ms) 0.79 0.34 0.52 0.13 0.381
fAHP Amplitude (mV) -24.00 4.76 -23.12 0.76 0.751
Supplementary Table 3.3. Passive membrane properties and single AP characteristics of non-fast-spiking and 
fast-spiking human interneurons. AP frequency was quantified as the mean AP frequency during a 500 ms, 300 pA 
square-wave current pulse. AP, action potential. fAHP, fast after-hyperpolarization. Ri, input resistance. RMP, resting 
membrane potential. P-values are based on Student’s t-test.
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Abstract
 Axonal myelination of neocortical pyramidal neurons is dynamically modulated 
by neuronal activity. Recent studies have shown that a substantial proportion of 
neocortical myelin content is contributed by fast-spiking, parvalbumin (PV)-positive 
interneurons. However, it remains unknown whether the myelination of PV+ 
interneurons is also modulated by intrinsic activity. Here, we utilized cell-type specific 
Designer Receptors Exclusively Activated by Designer Drugs (DREADDs) in adult 
male and female mice to activate a sparse population of medial prefrontal cortex 
PV+ interneurons. Using single-cell axonal reconstructions, we find that DREADD-
stimulated PV+ interneurons exhibit a nearly two-fold increase in total length of 
myelination, predominantly mediated by a parallel increase of axonal arborization and 
number of internodes. In contrast, the distribution of axonal inter-branch segment 
distance and myelin internode length were not significantly altered. Topographical 
analysis revealed that myelination of DREADD-stimulated cells extended to higher 
axonal branch orders, while retaining a similar inter-branch distance threshold 
for myelination. Together, our results demonstrate that chemogenetically-induced 
neuronal activity increases the myelination of neocortical PV+ interneurons 
mediated at least in part by an elaboration of their axonal morphology.
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Introduction
 Myelination functions critically to enable complex neuronal function, including 
learning and cognition. Recent studies have shown that a substantial fraction of 
myelination in the cerebral cortex is localized to fast-spiking, parvalbumin-positive 
(PV) interneurons.216,240 PV+ interneuron myelination is topographically-biased 
towards the proximal axon and constrained by local axonal morphology, including 
branch points and en passant boutons.240
 In addition, recent studies have shown that myelination is activity-dependent.25,27 
Optogenetic neuronal stimulation selectively increases oligodendrogenesis and 
myelination in mice19, and neuronal activity biases axonal selection and myelin 
topography in zebrafish241,242. Complex motor skill learning requires the production 
of new oligodendrocytes33, monocular deprivation leads to both oligodendrogenesis 
and reduced internode length22, and social isolation negatively influences 
oligodendrocyte morphological complexity with a concomitant reduction of 
internode density and g-ratio.209
 An important outstanding question is whether PV+ interneuron myelination is 
similarly dependent upon neuronal activity. In the present study, we utilize cell-specific 
Designer Receptor Exclusively Activated by Designer Drug (DREADD) technology 
to confirm that activity-dependent myelination extends to PV+ interneurons in the 
adult brain. Electrophysiological recordings with single cell labeling of manipulated 
cells permitted the coordinated examination of axonal morphology and myelin 
topography, revealing an activity-dependent enhancement of PV+ interneuron 
myelination that could be largely explained by an elaboration of axonal arborization 
with a parallel increase of internode number.
Results
Chemogenetic activation increases parvalbumin interneuron 
myelination
 
 We utilized in vivo cell-specific expression of activating Designer Receptor 
Exclusively Activated by Designer Drug (DREADD)243, followed by ex vivo whole-
cell electrophysiology and single-cell axonal reconstructions (Fig. 4.1a). Adult PV::cre 
mice233 received bilateral stereotactic injections in the medial prefrontal cortex 
(mPFC), utilizing adeno-associated viruses (AAV) with cre-dependent expression 
of unilateral hM3Dq-mCherry and contralateral GFP (Fig. 4.1b,c). Four weeks 
post-transduction, mice were given intraperitoneal administrations of clozapine 
n-oxide (CNO; 1 mg/kg, twice daily) for 14 consecutive days. Viral transduction 
was highly specific for PV+ cells with a similarly high cell-type specificity of hM3Dq-
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mCherry and GFP vectors (Fig. 4.1d,e). Sixteen hours after the last intraperitoneal 
CNO injection, ex vivo whole-cell recordings with post hoc biocytin labeling were 
performed in hM3Dq-mCherry+ cells and contralateral GFP+ cells from mPFC layer 
V (Fig. 4.2a,b). hM3Dq-mCherry+ and GFP+ cells exhibited subthreshold membrane 
potential oscillations, a suprathreshold high-frequency non-adapting pattern of 
action potential firing, and a large amplitude fast after-hyperpolarization, consistent 
with a fast-spiking, PV+ interneuron identity. No differences were observed between 
hM3Dq-mCherry+ and GFP+ cells in baseline membrane properties or single action 
potential characteristics (Fig. 4.2c-j).
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Figure 4.1. PV+ interneuron-specific DREADD expression. (a) Experimental design. Adult PV::cre mice were virally 
transduced with pseudorandomly assigned unilateral hM3Dq-mCherry and contralateral GFP. Twenty-eight days post-
surgery, mice were injected twice daily with 1 mg/kg CNO intraperitoneally for 14 days. One day after the last injection, 
mice were sacrificed and labeled cells were electrophysiologically recorded in whole-cell configuration. Biocytin-filled 
cells were imaged and axons were reconstructed including myelination. (b) Representative low-magnification confocal 
image of a bilateral injection of hM3Dq-mCherry (red) and GFP (yellow) at +2.1 mm from Bregma. Scale bar, 500 μm. 
(c) Schematic projection of injection areas from n = 10 mice for hM3Dq-mCherry (red) and GFP (green), with color 
intensity indicating number of mice. (d) Top: Maximum projection confocal image of co-localized GFP (yellow) and PV 
(cyan) immunofluorescence. Scale bar, 10 µm. Bottom: Maximum projection confocal image of co-localized hM3Dq-
mCherry (red) and PV (cyan) immunofluorescence. Scale bar, 10 µm. (e) Quantification of colocalization between 
hM3Dq-mCherry (red), GFP (green) and PV immunofluorescence. Transduction efficiency was similarly high for both 
vectors [P(GFP+|PV+): 77.0 ± 2.7%, P(hM3Dq-mCherry+|PV+): 80.9 ± 1.7%; t(4) = 1.218, P = 0.290]. Transduction 
specificity was also similarly high [P(PV+|GFP+): 87.6 ± 6.1%, P(PV+|hM3Dq-mCherry+): 93.5 ± 3.6%; t(4) = 0.844, 
P = 0.446]. n = 3 mice. Unpaired two-tailed Student’s t-tests in (e). Bars represent mean ± s.e.m. n.s. non-significant.
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To determine the influence of DREADD receptor activation on PV+ interneurons, 
we performed ex vivo electrophysiological recordings of hM3Dq-mCherry+ and 
GFP+ cells in the presence of CNO (Fig. 4.3a). Local application of CNO resulted 
in membrane depolarization followed by a robust increase in firing frequency of 
hM3Dq-mCherry+ cells (Fig. 4.3b). Similarly, bath application of CNO (5 µM) induced 
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Figure 4.2. Fluorescence-targeted whole-cell electrophysiological recordings from hM3Dq-mCherry and 
contralateral GFP cells. (a,b) Representative differential interference contrast (DIC) and epifluorescence images of 
hM3Dq-mCherry+ (a) and GFP+ (b) cells exhibiting a fast-spiking action potential (AP) train. Scale bars are 15 μm 
(left) and 20 mV, 100 pA and 100 ms from top to bottom (right). (c-j) In the absence of CNO, hM3Dq-mCherry+ (n 
= 23; red diamonds) and GFP+ cells (n = 13; green diamonds) were electrophysiologically similar : (c) input resistance 
(hM3Dq-mCherry: 167.1 ± 10.5 MΩ; GFP: 166.7 ± 17.6 MΩ; U = 153.000, P = 0.749), (d) resting membrane potential 
(hM3Dq-mCherry: -68.4 ± 1.0 mV; GFP: -68.6 ± 0.8 mV; t(33) = -0.182, P = 0.857), (e) AP threshold (hM3Dq-mCherry: 
-36.4 ± 1.7 mV; GFP: -33.6 ± 1.4 mV; t(33) = 1.124, P = 0.269), (f) AP amplitude (hM3Dq-mCherry: 82.6 ± 2.3 mV; GFP: 
77.8 ± 4.8 mV; t(33) = -0.918, P = 0.371), (g) fast after-hyperpolarization (hM3Dq-mCherry: -18.7 ± 0.9 mV; GFP: -20.6 ± 
0.8 mV; t(33) = -1.340, P = 0.189), (h) AP half-width (hM3Dq-mCherry: 0.34 ± 0.01 ms; GFP: 0.34 ± 0.02 ms; t(33) = 0.001, 
P = 0.999). (i) A small increase of AP rise time was observed in hM3Dq-mCherry+ cells (hM3Dq-mCherry: 0.22 ± 0.01 
ms; GFP: 0.19 ± 0.01 MΩ; U = 202.500, P = 0.041). (j) Evoked AP firing was unchanged between hM3Dq-mCherry+ 
and GFP+ cells (F(19,570) = 0.988, P = 0.473; repeated measures ANOVA). Unpaired two-tailed Student’s t-tests in (d) 
through (h). Mann-Whitney two-tailed U-test for (c) and (i) owing to non-normality. Black bars represent mean ± s.e.m. 
AP action potential; fAHP fast after-hyperpolarization; Vm membrane voltage; I current injection.
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a ~5 mV membrane depolarization in hM3Dq-mCherry+ cells (Fig. 4.3c), while no 
changes were observed in GFP+ cells (Fig. 4.3d). Therefore, CNO administration 
selectively increased activity in hM3Dq-mCherry+ cells.
 We next sought to examine whether DREADD-mediated activation of PV+ 
interneurons modulates their myelination. Therefore, we performed Neurolucida 
reconstructions of proximal axons of biocytin-labelled hM3Dq-mCherry+ (Fig. 
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Figure 4.3. Ex vivo characterization of 
CNO-dependent DREADD stimulation. (a) 
Experimental overview. A puff pipette was used 
for local application of CNO. (b) Local CNO 
(10 μM) application elicited strong membrane 
depolarization with a fast-spiking AP train. (c,d) 
Bath application of 5 μM CNO induced a ~5mV 
depolarization of hM3Dq-mCherry+ cells (red; 
baseline: -69.09 ± 1.43 mV; CNO:  63.90 ± 1.59 
mV; t(8) = -5.963, P < 0.001; n = 9 cells), while 
CNO had no effect on GFP+ cells (green; baseline: 
-69.11 ± 1.67 mV; CNO: -68.78 ± 1.94 mV; t(8) = 
-0.555, P = 0.594; n = 9 cells). Black lines indicate 
means. Paired Student’s two-tailed t-test in (c) and 
(d). *** P < 0.001. n.s. non-significant.
Figure 4.4. DREADD-activated cells have increased myelination. (a,b) Maximum projection confocal images of 
representative biocytin-filled hM3Dq-mCherry+ (a, red) and GFP+ (b, yellow) cells. Scale bars are 50 µm. (c) Left: Post 
hoc confirmation demonstrating that putative hM3Dq-mCherry+ biocytin-labeled cells (red) were hM3Dq-mCherry+ 
(purple). Right: Post hoc confirmation that putative GFP+ biocytin-labeled cells (yellow) were GFP+ (grey). Scale bars 
are 10 μm. (d) Reconstructed cells were located at similar cortical depths (hM3Dq-mCherry [red diamonds]: 394.5 ± 
42.3 μm; GFP [green diamonds]: 369.8 ± 36.5 μm; U = 61.000, P = 0.832). (e) Top: Low-magnification confocal image of 
a biocytin-labeled PV+ interneuron (red), with myelinated internodes revealed by MBP immunofluorescence (green). 
Arrowheads indicate myelinated internodes belonging to the biocytin-labeled cell. Scale bar, 10 μm. Bottom: High-
magnification confocal maximum projection image of a biocytin-labeled (red), myelinated (MBP; green) axonal segment. 
Scale bar 5 μm. (f,g) Proximal axonal reconstruction (left) with indicated segmental myelination of hM3Dq-mCherry+ 
(f) and GFP+ (g) cells shown in (a) and (b) respectively, with their corresponding schematic dendrogram representation 
(right). Soma and axon in grey, myelin in green. Horizontal axis, μm. (h) All examined hM3Dq-mCherry+ (red, n = 12) 
and GFP+ cells (green, n = 14) show myelination. (i) hM3Dq-mCherry+ cells show a higher total amount of myelin per 
cell, compared to GFP+ cells. hM3Dq-mCherry: 230.3 ± 42.4 μm myelin/cell; GFP: 117.9 ± 25.1 μm myelin/cell; t(24) = 
2.359, P = 0.027. (j) hM3Dq-mCherry+ cells show a greater number of internodes per cell, compared to GFP+ cells 
(hM3Dq-mCherry: 10.4 ± 1.3 internodes/cell; GFP: 5.6 ± 1.0 internodes/cell; t(24) = 3.008, P = 0.006). (k) Internode 
length is similar between hM3Dq-mCherry+ and GFP+ cells (hM3Dq-mCherry: 23.2 ± 1.2 μm, n = 99 internodes; GFP: 
19.9 ± 1.3 μm, n = 75 internodes; t(172) = 1.888, P = 0.061). (l) hM3Dq-mCherry+ cells have an increased number of 
internodes beginning from 4th branch order axonal segments distally (F(12,240) = 2.890, P < 0.001, repeated measures 
ANOVA). (m) hM3Dq-mCherry+ and GFP+ cells have a similar myelination onset (hM3Dq-mCherry: 1.7 ± 0.4; GFP: 
1.9 ± 0.5; U = 89.000, P = 0.574). (n) In contrast, the most distal branch order showing myelination is located further 
along the axon in hM3Dq-mCherry+ cells (hM3Dq-mCherry: 7.6 ± 0.4; GFP: 5.3 ± 0.3; t(21) = 4.387, P < 0.001). ***P < 
0.001, **P < 0.01, *P < 0.05, n.s. non-significant. Unpaired Student’s two-tailed t-test in (i), (j), (k) and (n); Mann-Whitney 
two-tailed U test in (d) and (m) owing to non-normality. Black bars represent mean ± s.e.m.
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4.4a,c,f) and GFP+ cells (Fig. 4.4b,c,g) including myelination (Fig. 4.4e). hM3Dq-
mCherry+ and GFP+ cells were located at a similar depth within the mPFC (Fig. 
4.4d). Consistent with previous findings in PV+ interneurons240, all reconstructed 
hM3Dq-mCherry+ and GFP+ cells exhibited axonal myelination (hM3Dq-mCherry: 
14/14 cells, 100%; GFP: 12/12 cells, 100%) (Fig. 4.4h). Notably however, hM3Dq-
mCherry+ cells exhibited an increase of total length of axonal myelination per 
neuron (Fig. 4.4i), driven primarily by an increase in the number of internodes 
(Fig. 4.4j). Internode length showed a trend towards longer internodes in hM3Dq-
mCherry+ cells but was statistically unchanged (Fig. 4.4k). Topographical analysis of 
axonal reconstructions revealed that the enhanced myelination of hM3Dq-mCherry+ 
cells occurred along 4th – 9th axonal branch order segments (Fig. 4.4l), for which 
hM3Dq-mCherry+ cells exhibited a significantly higher axonal branch order of distal 
myelination compared to GFP+ cells (Fig. 4.4n) while the initial onset of myelination 
was unchanged (Fig. 4.4m). Together, these data show that chemogenetic activation 
of PV+ interneurons enhances their myelination through an increased number and 
more distally extended distribution of axonal internodes. 
Cell-specific activation results in axon morphology changes
 We next sought to explore whether changes in axonal morphology might 
underlie the observed increase in total myelination on DREADD-stimulated PV+ 
interneurons. Therefore, we reconstructed the axon of each cell, beginning from 
the axon initial segment until the occurrence of a string of en passant boutons 
(≥3 consecutive boutons on a single axonal branch located within 15 µm) on 
each terminal branch. Consistently, DREADD-stimulated PV+ interneurons had 
a significantly more elaborated axonal morphology compared to GFP+ controls 
(Fig. 4.5a,b; 4.6a,b). Using Sholl analysis, hM3Dq-mCherry+ cells exhibited a greater 
Figure 5
1 column 1.5 column 2 columns
a hM3Dq-mCherry GFP
c d
b
0 25 50 75 10
0
12
5
15
0
17
5
20
0
22
5
25
0
0
5
10
Radius (µm)
N
um
be
ro
fI
nt
er
se
ct
io
ns
0 25 50 75 10
0
12
5
15
0
17
5
20
0
22
5
25
0
0
100
200
300
400
500
Radius (µm)
A
xo
n
Le
ng
th
(µ
m
) hM3Dq-mCherry
GFP
Figure 4.5. Sholl analysis reveals activity-
dependent enhancement of proximal 
axonal complexity in PV+ interneurons. 
(a,b) Representative Sholl analysis for 
hM3Dq-mCherry+ (a) and GFP+ (b) 
cell axons. Radial spacing, 25 μm. Colors 
indicate distinct centrifugal branch orders. 
(c,d) Number of intersections per Sholl 
(c; F(10,210) = 4.073, P < 0.001, repeated 
measures ANOVA) and axonal length per 
Sholl (d; F(6,60) = 3.664, P = 0.004, repeated 
measures ANOVA) were significantly 
increased in hM3Dq-mCherry+ cells (red 
diamonds) compared to GFP+ cells (green 
diamonds). Black bars represent s.e.m.
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Figure 4.6. Branch structure analysis. (a,b) Representative proximal axon reconstruction from hM3Dq-mCherry+ 
(a) and GFP+ (b) cells. (c,d) Corresponding axonal dendrogram of hM3Dq-mCherry+ and GFP+ cells shown in (a) 
and (b). Branch orders are centrifugally designated. Horizontal axis, μm. (e) Total proximal axon length is greater in 
hM3Dq-mCherry+ (red diamonds) compared to GFP+ cells (green diamonds; hM3Dq-mCherry: 1499.9 ± 205.9 μm; 
GFP: 985.4 ± 90.9 μm; t(21) = 2.214, P = 0.038). (f) hM3Dq-mCherry+ cells have a greater number of branch points 
compared to GFP+ cells (hM3Dq-mCherry: 44.3 ± 4.2; GFP: 29.5 ± 2.3; t(21) = 3.003, P = 0.007). (g) hM3Dq-mCherry+ 
cells exhibited an increased number of axonal segments on higher order (≥5th branch order) axonal segments (F(12,252) 
= 3.428, P < 0.001), while (h) inter-branch point distance remained unchanged (F(11,44) = 0.712, P < 0.721). **P < 0.01; 
*P < 0.05. n.s. non-significant. Unpaired Student’s two-tailed t-test in (e) and (f). Repeated measures ANOVA in (g) and 
(h). Black bars represent mean ± s.e.m.
number of intersections and longer axonal length compared to GFP+ cells (Fig. 
4.5c,d). Moreover, branch structure analysis (Fig. 4.6a-d) also confirmed that 
hM3Dq-mCherry+ cells had a longer axonal length (Fig. 4.6e) as well as an increased 
number of branch points (Fig. 4.6f), beginning from the 5th branch order distally (Fig. 
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4.6g). The average inter-branch point distance also remained unchanged (Fig. 4.6h). 
Together these data indicate that PV+ interneurons exhibit a robust and highly 
specific activity-dependent elaboration of their axonal morphology following in vivo 
stimulation in the adult neocortex. 
Activity-driven myelin increases are proportional to axonal 
morphology changes
 Given that DREADD-stimulated PV+ interneurons exhibit increased myelination 
and altered axonal morphology, we examined whether the increase in myelination 
was proportional to the change in axonal complexity. For each cell, we examined 
the proportion of axonal segments per branch order that contained internodes 
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Figure 4.7. Enhanced segmental myelination 
is proportional to the elaboration of axonal 
morphology. (a-b) Representative PV+ interneuron 
reconstruction (left) and corresponding axonal 
dendrogram (right) for hM3Dq-mCherry+ (a) and 
GFP+ cells (b). Myelinated segments are shown 
in green. Horizontal axis, μm. (c) Both hM3Dq-
mCherry+ cells (red diamonds) and GFP+ cells 
(green diamonds) exhibit a decreasing myelination 
fraction over increasing branch order (F(12,252) = 
23.823, P < 0.001, repeated measures ANOVA, 
main effect of branch order). hM3Dq-mCherry+ 
cells have a similar proportion of myelinated 
segments as GFP+ cells across the entire axonal 
arbor (F(12,252) = 1.206, P = 0.279, repeated 
measures ANOVA). (d) Consistent with the 
elaboration of their axonal arborization, hM3Dq-
mCherry+ cells contain myelinated segments on 
more distally extended axonal segments. Black 
bars represent mean ± s.e.m.
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(myelination fraction). Both hM3Dq-mCherry+ and GFP+ cells showed a 
progressively decreasing myelination fraction with increasing branch order (Fig. 
4.7a-c). Moreover, hM3Dq-mCherry+ cells exhibit a similar myelination fraction 
extending to the distal limit of GFP+ cells (Fig. 4.7c), beyond which hM3Dq-
mCherry+ cells exhibit additional myelinated segments along their extended axonal 
length (Fig. 4.7d). Together, these data suggest that the activity-dependent increase 
in myelination of PV+ interneurons is predominantly mediated by the elaboration of 
axon morphology.
Myelination is restricted by axonal distance between branch 
points
 Previous studies have reported that proximal axon myelination most commonly 
occurs on uninterrupted axonal segments of at least ~15 µm.240  Therefore, we 
examined whether activity-induced myelination changed these requirements. We 
quantified inter-branch point distances from the soma up to 5th order axonal 
segments, including whether these segments contained an internode. Unmyelinated 
inter-branch point segments were consistently shorter than corresponding myelinated 
segments in both GFP+ cells and hM3Dq-mCherry+ cells (Fig. 4.8a). Overall, inter-
branch segments >40 µm were frequently myelinated (91.6%), while inter-branch 
segments <15 µm tended to be unmyelinated (96.2%). An analogous dichotomy was 
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Figure 4.8. The inter-branch distance threshold for segmental myelination remains unchanged. (a) Quantification of 
inter-branch point distance for myelinated versus unmyelinated segments (2nd-5th branch order). Myelinated axonal 
segments for hM3Dq-mCherry+ (red diamonds) and GFP+ cells (green diamonds) are significantly longer than 
unmyelinated axonal segments (brown and dark green, respectively; hM3Dq-mCherry: t(83) = 3.554, P = 0.002; GFP: t(71) 
= 5.949, P < 0.001). Length of neither myelinated, nor unmyelinated, segments differed between hM3Dq-mCherry+ 
or GFP+ cells (hM3Dq-mCherry myelinated: 36.2 ± 5.3 μm; hM3Dq-mCherry unmyelinated: 16.6 ± 1.6 μm; GFP 
myelinated: 41.0 ± 4.3 μm: GFP+ unmyelinated: 13.5 ± 1.7 μm). n = 3 cells per region. n.s. non-significant, t(36) = -0.699, P 
= 0.489 for myelinated and t(118) = 1.325, P = 0.188 for unmyelinated segments, respectively. (b) The first axonal branch 
point was located closer to the soma when it arose before, rather than after, the first myelinated internode in both 
hM3Dq-mCherry+ and GFP+ cells. hM3Dq-mCherry: t(11) = 2.202, P = 0.050; GFP: t(11) = 4.025, P = 0.002. n.s. non-
significant, t(14) = -1.342, P = 0.201 for myelinated and t(7) = 0.188, P = 0.856 for unmyelinated segments, respectively. 
***P < 0.001; **P < 0.01. Unpaired Student’s two-tailed t-tests in (a) and (b). Black bars represent mean ± s.e.m.
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hM3Dq-mCherry transduced hemispheres (t(3) = 0.908, P = 0.431; n = 4 mice). (f) Confocal overview image of CC1+ 
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s.e.m. n.s. non-significant
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also evident in the location of the first axonal branch point, which was positioned 
closer to the soma when it arose before, compared to after, the first internode of 
both hM3Dq-mCherry+ and GFP cells+ (Fig. 4.8b). These findings suggest that the 
activity-driven increase of PV+ interneuron myelination is proportional to increase 
in total axonal length, while maintaining a similar topography of axonal morphology 
and myelination.
No alterations in total myelin content or oligodendrocyte number
 Prior studies using optogenetic and chemogenetic pyramidal cell activation have 
demonstrated substantial increases in total myelin content and oligodendrocyte 
lineage cell density.19,20 Therefore, we sought to examine the cell-type specificity of 
the activity-dependent changes in PV+ axonal myelination by quantifying both total 
myelin content and oligodendrocyte density in the surrounding volume. We performed 
immunofluorescent stainings for myelin (MBP) and mature oligodendrocytes (CC1) 
in hM3Dq-mCherry+ and GFP+ transduced areas (Fig. 4.9a). In contrast to previous 
studies involving pyramidal cell stimulation, we did not find evidence for changes of 
total myelin content (Fig. 4.9b-e) or oligodendrocyte density (Fig. 4.9f-h) between 
hM3Dq-mCherry+ and GFP+ transduced areas. Accordingly, the observed activity-
dependent changes in PV+ axonal morphology and myelination appear likely to be 
cell autonomous.
Discussion
 In the present paper, we examined whether in vivo activity-dependent 
myelination occurs in neocortical fast-spiking, PV+ interneurons. Utilizing cell-
specific chemogenetic activation followed by single-cell reconstructions of PV+ 
interneurons in the adult mouse mPFC, we found that in vivo stimulation of PV+ 
interneuron activity induced a ~50% increase in proximal axonal length with a 
proportional increase in myelination. These findings add to the understanding of 
dynamic myelination, but our results suggest that, at least for PV+ interneurons, this 
is mediated significantly by activity-dependent plasticity of axonal morphology.
 Employing single-cell reconstructions allowed us to comprehensively document 
the position of each myelinated segment along the axon, in contrast to previous 
studies using larger-scale analyses.19 We found that stimulated cells exhibited 
increased myelination of more distal axon segments (branch order ≥4), while 
myelination did not differ on more proximal branch orders. Furthermore, due to 
bilateral transfection with either DREADDs or GFP, we could reconstruct cells from 
both hemispheres under similar conditions, thereby minimizing possible experience-
dependent variation. Finally, our studies were performed in adult mice, thereby 
 86 
reducing the likelihood of neurodevelopmental interactions. As a corollary, whether 
activity-dependent PV+ myelination is regulated similarly during neurodevelopment 
is an important question that remains to be determined.
 A limitation of the current study is that we could not follow the evolution of 
axonal and myelination changes longitudinally over time. Therefore, the time course 
of the observed changes of axonal morphology and myelination remain unknown, 
as well as a definitive confirmation that the changes in axonal morphology precede 
the increase in myelination. Moreover, it remains unknown which specific axonal 
parameters govern the increase of PV+ interneuron myelination. Our findings suggest 
that a substantial proportion of the increase in myelination is mediated by an activity-
induced elaboration of PV+ interneuron axonal arborization244 which is subsequently 
myelinated. Another candidate is axon diameter, which has been shown to change 
rapidly upon neuronal activity in CA3 pyramidal cells245 and has been demonstrated 
to function as a critical biophysical threshold permissive for myelination.246,247 Lastly, 
an activity-dependent modulation of vesicular release probability could also be an 
important determinant, as axonal vesicular release has been shown to regulate 
the differentiation to myelinating oligodendrocytes of oligodendrocyte progenitor 
cells in close proximity to unmyelinated axonal segments.242,248 The increase of 
axonal myelination appears to result from the addition of internodes, since the 
distribution of internode length is largely preserved (Fig. 4.4k). In line with previous 
findings,240 we also find that the pattern of myelination along axons of stimulated 
PV+ interneurons is constrained by a similar inter-branch segment length threshold 
(Fig. 4.8). This suggests that although neuronal activity can dynamically modulate 
axonal morphology, there is yet no evidence for activity-dependent plasticity of the 
fundamental biophysical parameters dictating the eligibility of myelination at a given 
axonal segment.
 Given previous reports that cell-type specific stimulation of cortical pyramidal 
neurons resulted in observable changes of total myelin content and oligodendrocyte 
density, we similarly assessed the cell-type specificity following chemogenetic 
activation of PV+ interneurons. Notably however, we did not find changes in 
oligodendrocyte density or overall myelin labeling. We suggest two possibilities 
for the absence of an observable difference of these metrics. First, given that PV+ 
interneurons contribute only a small minority of the total myelin content in the 
mPFC240, and that virally-labeled cells constitute only a subset of PV+ interneurons 
within the transduced areas, the possibility exists that changes in the number of 
oligodendrocytes due to PV+ activation might have been too small to be observed 
using volumetric quantification. Moreover, with regard to total myelin content, the 
limitation of a volumetric quantification might therefore also be considered likely 
on the basis of the demonstrated increase of myelination per chemogenetically-
activated PV+ interneuron (Fig. 4.4). The second non-mutually exclusive possibility is 
predicated upon the established function of PV+ interneurons as strong modulators 
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of local network activity.47 In this scenario, PV+ interneuron-mediated inhibition 
of principal cell firing might lead to reductions in myelination of an equivalent 
magnitude as the increase in myelination of PV+ interneurons.
 Together, we identify a novel form of activity-dependent myelination mediated 
by axonal morphological plasticity of PV+ interneurons. These findings contribute 
to the increasing evidence demonstrating the dynamic plasticity of adult neocortical 
myelination and axonal morphology.
Methods
Mice
 All experiments were approved by the Dutch Ethical Committee and in 
accordance with the Institutional Animal Care and Use Committee (IACUC) 
guidelines. Mouse lines were obtained from Jackson Laboratory: 
 Pvalbtm1(cre)Arbr/J mice (PV::cre)233    strain #008069 
 C57BL/6J (WT)       strain #000664 
All lines were backcrossed for more than 10 generations in C57BL/6J. Adult mice of 
both genders were used from 8-12 weeks of age. Mice were group-housed in same-
sex groups of two to four mice and maintained on a 12 h light/dark cycle with ad 
libitum access to food and water. After surgery, mice were single-housed until further 
experiments.
Viral Labeling and CNO injections
 Heterozygous PV::cre mice were used for viral-mediated cell-type specific labelling, 
performed using adeno-associated virus (AAV) expression with cre-dependent 
AAV5/hSyn-DIO-hM3Dq-mCherry and AAV5/hSyn-DIO-GFP (University of 
Pennsylvania Viral Vector Core). Virus was diluted to ~5 x 1011 GC/ml in phosphate-
buffered saline (PBS) to achieve sparse labelling. hM3Dq-mCherry and GFP control 
injections were counterbalanced between the left and right hemisphere. All mice 
showed successful bilateral virus expression with no contralateral contamination.
 Anesthesia was induced using 5% isoflurane (O2 flow of 0.5 L/min), and 
subsequently maintained with 1-2% isoflurane during surgery. Body temperature was 
maintained at 37°C. Mice were placed into a custom-made stereotaxic frame using 
a mouth bar (Stoelting) for head fixation. Analgesia was provided systemically by 
subcutaneous Temgesic injection (buprenorphine 0.5 mg/kg) and locally by xylocaine 
spray (100 mg/mL; AstraZeneca) directly applied on the skull. To access the brain, a 
longitudinal scalp incision of ~1 cm length was made to reveal the skull, and a small 
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craniotomy (<1 mm) was performed overlying the injection sites at the following 
coordinates (in mm):
 mPFC:  +1.75 bregma, ±0.35 lateral, -1.9 dorsoventral 
Mice used for electrophysiological recordings received 1 µL in a ½ dilution. Virus 
was aspirated in a borosilicate glass micropipette, which was slowly lowered to the 
target site. Virus injection was controlled by an automated syringe pump (infusion 
speed 0.1 μl/min). At the conclusion of the injection, the micropipette was maintained 
in place for another 5 min and then slowly withdrawn. The surgical wound was 
closed with skin-glue (Derma+flex). Mice were left to recover for 28 days to allow 
expression of hM3Dq-mCherry and GFP protein. To optimize the bilateral virus 
injection symmetry necessary for consequent bilateral electrophysiology, we took 
particular care at a few key points: 1) Mouse skulls were always carefully vertically 
leveled based on bregma and lambda, 2) glass micropipettes were always checked to 
run properly before injections, and were carefully cleaned to remove excess virus 
particles, 3) drill holes were kept as small as possible (<1 mm), and 4) mice were left 
to recover for exactly 28 days before starting clozapine n-oxide (CNO) injections 
to minimize expression variations between mice.
 After 28 days of recovery, mice were injected intraperitoneally with CNO 
(Sigma) 1 mg/kg twice daily (at ~9:00h and ~18:00h) for 14 consecutive days. Mice 
displayed no weight loss over the injection period (day 1: 26.2 ± 1.5 g; day 14: 24.8 
± 1.1 g; P = 0.458; Paired two-tailed t-test) or overt behavioral abnormalities under 
CNO administration.
Electrophysiology
 The next morning after the last CNO injection, mice were anesthetized using 
5% isoflurane and decapitated in ice-cold, NMDG-based cutting solution containing 
(in mM): 93 N-methyl-d-glucamine (NMDG), 93 HCl, 30 NaHCO3, 25 D-glucose, 20 
HEPES, 5 Na-ascorbate, 2 thiourea, 10 MgCl2, 3 Na-pyruvate, 2.5 KCl, 1.25 NaH2PO4 
and 0.5 CaCl2 (300 mOsm, pH 7.4) oxygenated with 95% O2/5% CO2. Coronal slices 
(300 μm) were cut with a vibrating slicer (Microm HM 650V, Thermo Scientific) 
and incubated in cutting solution at 37 °C for 8 min, followed by oxygenated (95% 
O2/5% CO2) artificial cerebrospinal fluid (aCSF) at 37 °C for another 10 min. ACSF 
contained (in mM) 127 NaCl, 25 NaHCO3, 25 D-glucose, 2.5 KCl, 1.25 NaH2PO4, 
1.5 MgSO4 and 1.6 CaCl2. Slices were then allowed to recover at room temperature 
for at least 1 h before recordings.
 PV+ interneurons from the prelimbic region layer V of the mPFC were 
visualized by mCherry or GFP fluorescence using a TXRED or GFP filter (Semrock, 
Rochester, NY, USA), respectively. Importantly, GFP+ control cells were recorded 
from contralateral hemispheres of the same coronal slices as recorded hM3Dq-
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mCherry+ cells, and cells were recorded from equal distances from the midline 
(Fig. 4.4d). To minimize variation in proportion of missing axon due to slicing, cells 
were consistently patched at a depth of 20-50 μm from the slice surface. Whole-
cell recordings were made using borosilicate glass pipettes (3.5–5.5 MΩ resistance) 
with intracellular solution containing (in mM) 120 K-gluconate, 10 KCl, 10 HEPES, 
10 K-phosphocreatine, 4 ATP-Mg, 0.4 GTP, and 5 mg/ml biocytin (pH was adjusted to 
7.4 using KOH, and osmolarity measured 285-290 mOsm). All recorded mCherry+ 
and GFP+ cells had a fast-spiking phenotype, with subthreshold membrane potential 
oscillations, suprathreshold high-frequency, non-adapting firing patterns, and large 
amplitude fast after-hyperpolarizations. Cells were filled for at least 25 min. for 
proper biocytin spreading.
 Recordings were performed in aCSF at near-physiological temperatures (33 ± 
1°C) using HEKA EPC10 quattro amplifiers and Patchmaster software (40 kHz). 
Series resistance was typically <25 MΩ and fully compensated for bridge balance 
and capacitance. No correction was made for liquid junction potential. Data analysis 
was performed offline using Igor Pro v6 (Wavemetrics).
 Basic physiological characteristics were determined from voltage responses to 
square-wave current pulses of 500 ms duration, ranging from –100 pA to +300 pA, 
and delivered in 20 pA intervals. Input resistance was determined by the slope of 
the linear regression through the voltage-current curve. Single action potential (AP) 
characteristics were obtained from the first elicited action potential. AP threshold 
was defined as the inflection point at the foot of the regenerative upstroke. AP 
amplitude was defined as the voltage difference between the threshold and peak 
voltage. AP half-width was measured at half of the peak amplitude. AP rise time 
was quantified as duration from 10% to 90% of the peak amplitude. The fast after-
hyperpolarizing potential (fAHP) amplitude was measured as the hyperpolarizing 
deflection from AP threshold following AP initiation. 
 
 Local application of CNO was performed at a concentration of 10 µM (in 0.9% 
NaCl) through a borosilicate glass pipette (3.5–5.5 MΩ resistance).  The pipette was 
backfilled with CNO and positioned at a distance of ~20 μm from the recorded 
soma within the same focal plane. A total of 50 µL CNO (10 µM) was applied over 
250 ms at a fixed rate of 200 μL/sec.
Immunofluorescence
 For recovery of biocytin-labelled cells following electrophysiological recordings, 
300 μm slices were incubated overnight at 4°C in fresh 4% paraformaldehyde 
(PFA). Slices were extensively rinsed at room temperature in PBS, and stained in 
PBS buffer containing 0.4% Triton X-100, 2% normal horse serum (NHS; Invitrogen, 
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Bleiswijk, The Netherlands) and streptavidin-conjugated secondary antibody 488 
(1:300, Jackson; for hM3Dq-mCherry+ cells) or streptavidin-Cy3 (1:300; Invitrogen; 
for GFP+ cells) for 5 h at room temperature. Slices were washed with PBS and PB 
0.1M and mounted on slides, cover slipped with 200 µl Mowiol (Sigma), sealed, and 
immediately imaged for full axonal morphology (see Confocal Microscopy). To avoid 
excessive thinning or drying of 300 µm sections, cells were mounted, imaged and 
returned to PB 0.1 M directly after imaging.
 After full cell imaging, 300 µm slices were extensively washed in PB 0.1 M and PBS, 
and subsequently incubated overnight at 4°C in 30% sucrose (0.1 M PB). Sections 
were then carefully recut at 40 μm using a freezing microtome (Leica, Wetzlar, 
Germany; SM 2000R) and stored serially in 0.1 M PB at 4°C. Forty μm sections 
were washed with PBS and pre-incubated with a blocking PBS buffer containing 
0.5% Triton X-100 and 10% NHS for 1 h at room temperature. Sections were 
incubated in PBS buffer containing 0.4% Triton X-100 and 2% NHS for 72 h at 4°C 
and goat anti-MBP (1:300, Santa Cruz, C-16, sc-13914). Then, sections were washed 
with PBS, and incubated with corresponding Alexa-conjugated secondary antibodies 
(1:300, Invitrogen) and cyanine dyes (1:300, Sanbio, Uden, The Netherlands) in PBS 
buffer containing 0.4% Triton X-100, 2% NHS for 5 h at room temperature. For 
biocytin, streptavidin-A488 (1:300, Jackson) and streptavidin-Cy3 (1:300, Invitrogen) 
were again used. Nuclear staining was performed using DAPI (1:10.000, Invitrogen). 
Sections were washed with PB 0.1 M and mounted on slides, cover slipped with 
Vectashield H1000 fluorescent mounting medium (Vector Labs, Peterborough, UK), 
sealed and imaged.
 An independent group of mice received CNO injections for 14 days prior to 
transcardial perfusion using 4% PFA. Brains were resected, placed in 4% PFA for 
post-fixation (2 h) at room temperature, and subsequently stored in 10% sucrose 
solution (0.1 M PB) overnight at 4°C. The next day brains were embedded in gelatin 
(12% gelatin (Sigma-Aldrich)/10% sucrose), post-fixed (10% PFA/30% sucrose) for 2 
h at room temperature, and then stored in 30% sucrose solution overnight at 4°C. 
Coronal sections were made on a freezing microtome in 40 µm and collected in 
0.1 M PB. Subsequently, slices were similarly stained as described above for recut 
electrophysiology slices. The following primary antibodies were used: 
 rabbit anti-mCherry (1:500, Millipore, Abcam, ab167453) 
 chicken anti-GFP (1:2000, Aves) 
 mouse anti-PV (1:1000, Swant, 235) 
 goat anti-MBP (1:300, Santa Cruz, C-16, sc-13914) 
 mouse anti-CC1 (1:100, Merck, ab-7)
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Confocal Imaging and Analysis
 Confocal imaging was performed using a Zeiss LSM 700 microscope (Carl Zeiss) 
equipped with Plan-Apochromat 10x/0.45, 20x/0.8 and 63x/1.4 (oil immersion) 
objectives. DAPI, Alexa488, Cy3 and Alexa647, and were imaged using excitation 
wavelengths of 405, 488, 555, 639 nm, respectively.
 Reconstructions of biocytin-filled cells were obtained from 300 μm slices at 63x 
magnification with 1x digital zoom and a z-step size of 0.5 μm. For axonal myelin 
reconstructions, recut and restained 40 μm slices were imaged at 63x magnification 
with 1x digital zoom and a z-step size of 0.5 µm. All images were transferred 
to Neurolucida 360 software (v2.8; MBF Bioscience) and reconstructed using 
interactive tracing with the Directional Kernels method. Reconstructed soma, axon 
and myelin segments were analyzed with Neurolucida Explorer (MBF Bioscience). 
Axons were easily identified as the thinnest, smoothest, and most highly branched 
processes originating from either the soma or primary dendrite. In addition, axons 
seemed to branch at more obtuse ≥90° angles from one another, often turning back 
toward the soma, whereas dendrites branched at smaller angles (<90°), continuing a 
trajectory away from the soma. All reconstructed cells showed a classical basket cell 
morphology249, which is in line with a recent study showing absence of chandelier 
cells beyond mPFC layer II250.
 Myelinated axonal segments were defined as the circumferential bordering of a 
streptavidin-labelled axon by an MBP+ myelin signal. Myelin segments that exited a 
slice were removed from subsequent analysis. No spatial corrections were made for 
tissue shrinkage. 
 Transduction efficiency and specificity, as well as oligodendrocyte number, were 
measured in transduced regions in the prelimbic area of the mPFC (Bregma: +2.30 
till +1.70 mm) of brain slices from transcardially perfused mice. Stacked confocal 
images were obtained at 20x with 1x digital zoom and a z-step size of 3 µm. A 467 
µm x 467 µm x 12 µm counting frame was established for manual counting using the 
multi-point tool in Fiji image analysis software (version 2.0.0). Colocalization with 
PV was defined as a mCherry- or GFP-labeled soma overlapping with PV+ soma 
signal.
Statistical Analysis
 Statistical analysis was performed using IBM SPSS (version 23). All data sets were 
examined using Shapiro-Wilk test for normality. Data sets with normal distributions 
were analysed for significance using unpaired or paired Student’s two-tailed t-test 
or repeated measures analysis of variance (ANOVA) measures followed by Tukey’s 
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post hoc test. Data sets with non-normal distributions were analysed using Mann-
Whitney U test. Significance threshold was set at P < 0.05, and throughout the paper 
exact P-values values are provided except when P < 0.001. All data are expressed 
as mean ± standard error. On basis of previously published data sets240, we chose 
similar sample sizes for all experiments performed. Results are the combination of 
three animal cohorts that showed similar results. 
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Summary
 Myelination is the insulating ensheathment of axons by oligodendrocytes to 
increase action potential propagation and provide metabolic support. GABAergic 
interneurons are a heterogeneous group of predominantly local, inhibitory cells. 
In schizophrenia, a major debilitating psychiatric disorder, both myelination as well 
as functioning of GABAergic interneurons have independently been suggested 
to be impaired. Whether GABAergic interneurons themselves show myelination, 
remains unknown. Here, we show that GABAergic myelination has been extensively 
observed throughout various brain areas and different species. This interneuron 
myelination appears highly specific for the subclass of fast-spiking, parvalbumin (PV)-
expressing interneurons. Indeed, nearly every PV interneuron exhibits myelination 
on its proximal axons in the adult brain. Furthermore, PV interneuron myelination 
is dependent upon neuronal activity. Finally, axonal morphology is shown to be a 
major determinant for myelination of PV interneurons as well as other interneuron 
subclasses. Together, interneuron myelination presents a widespread novel 
phenomenon with interesting implications for brain functioning in health and disease.
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Samenvatting
 Myelinisatie is de omwikkeling van axonen door oligodendrocyten met als doel 
actiepotentialen te versnellen en axonen te voorzien van metabole ondersteuning. 
GABAerge interneuronen zijn een heterogene groep van hoofzakelijk lokale, 
inhibitoire cellen. Er zijn verschillende aanwijzingen dat in schizofrenie, een 
invaliderende psychiatrische stoornis, zowel myelinisatie als het functioneren 
van GABAerge interneuronen zijn aangedaan. Tot op heden is het onduidelijk of 
GABAerge interneuronen zelf gemyeliniseerd zijn. Hier laten wij zien dat myelinisatie 
van GABAerge interneuronen wel degelijk veelvuldig wordt geobserveerd in 
verschillende hersengebieden en diersoorten. De myelinisatie van interneuronen 
is specifiek voor de subklasse van snel-vurende, parvalbumine-positieve (PV) 
interneuronen. Bijna alle PV interneuronen in het volwassen brein zijn gemyeliniseerd 
op het proximale deel van het axon. Tevens laten wij zien dat PV interneuron 
myelinisatie in het volwassen brein afhankelijk is van neuronale activiteit. Tot slot 
lijkt axonale morfologie een van de belangrijkste voorspellers voor myelinisatie van 
zowel PV interneuronen als andere interneuron subklassen. Samenvattend vormt 
interneuron myelinisatie een ruimschoots aanwezig, nieuw fenomeen met mogelijk 
interessante implicaties voor het functioneren van het brein in gezondheid en ziekte.
 170 C
171 C
Curriculum Vitae
 Jeffrey Stedehouder was born 11 maart 1986 in Gouda, The Netherlands. He 
attained a BA degree in Egyptology and a BSc degree in Psychology from Leiden 
University in 2010, participating in the Honours Class as well as the Honours Research 
Bachelor Project under supervision of Prof. dr. Belle Derks. Afterwards, he attained 
his MSc degree in Neuroscience from the Erasmus University in 2012, during which 
he participated in the Exchange Honours Master Programme between Amsterdam 
and Rotterdam. From 2012 till 2018, he worked on his PhD thesis under supervision 
of Prof. dr. Steven Kushner at the Department of Psychiatry of the Erasmus MC in 
Rotterdam.
 174 
Publications
Present Thesis:
Stedehouder J, Brizee D, Slotman JA, Lehrer ML, Berson DM, Houtsmuller AB, Kushner  
 SA. Axonal morphology governs cortical interneuron myelination. (Manuscript   
 under review).
Stedehouder J*, Brizee D*, Shpak G, Kushner SA. (2018). Activity-dependent   
 myelination of parvalbumin interneurons mediated by axonal morphological plasticity.  
 Journal of Neuroscience. 38(15):3631- 3642. 
 Featured Article. Journal of Neuroscience. 38(15) 
Stedehouder J, Couey JJ, Brizee D, Hosseini B, Slotman J, Dirven CMF, Shpak G,   
 Houtsmuller AB, Kushner SA. (2017). Fast-spiking parvalbumin-positive interneurons   
 are frequently myelinated in the cerebral cortex in mouse and human. Cerebral Cortex.  
 27(10):5001-5013. 
Stedehouder J, Kushner SA. (2017). Myelination of parvalbumin interneurons. A   
 parsimonious locus of convergence in Schizophrenia pathophysiology. Molecular   
 Psychiatry. 22(1):4-12. 
Not in Thesis:
Stedehouder J, Mientjes E, Demmers J, Elgersma Y, Kushner SA. Laminin abnormalities in 
 schizophrenia. (Manuscript in preparation).
Stedehouder J, Bouwen BLJ, Gao Z, Dirven CMF, Hoogendijk WJG, Kushner SA. Whole- 
 cell electrophysiological recordings from a patient with bipolar disorder: A case study.  
 (Manuscript in preparation).
Avagliano Trezza R*, Sonzogni M*, Bossuyt SNV*, Izampela Zampeta F, Punt AM, Van den   
 Berg M, Munshi ST, Stedehouder J, Kros JM, Williams M, Heussler H, De Vrij FMS,   
 Mientjes E, Van Woerden GM, Kushner SA, Distel B*, Elgersma Y*. Angelman Syndrome- 
 associated mutations reveal mechanism and importance of UBE3A targeting to the   
 nucleus. (Manuscript in revision).
Markx S, Au E*, Karayannis T*, Wan Lai S*, D’Amour J*, Dilsiz P*, Stedehouder J,   
 Sosunov AA, Curley J, Levy R, Ellegood J, Stark K, Diamantopoulou A, Soldan SS, Purpura  
 M, Benzer C, Jacobs LM, Goldman J, Dwork AJ, Strauss KA, Ananth M, Robison L, Peles  
 E, Cherry SR, Henkelman M, Thanos PK, Winawer M, Lai W-S, Aoki C, Gan W, Fishell G,  
 Froemke, Kushner SA, Talos DM, Karayiougou M, Gogos JA. Inhibition of overactive   
 mTOR ameliorates core deficits in a mouse model of CNTNAP2-associated autism.   
 (Manuscript under review).P
175 
Amin N, De Vrij F, Baghdadi M, Brouwer R, Van Rooij J, Jovanova O, Uitterlinden A, Hofman  
 A, Janssen H, Darwish Murad S, Kraaij R, Stedehouder J, Van Den Hout MC, Kros   
 LM, Van IJcken WF, Tiemeijer H, Kushner SA, Van Duijn, CM. (2018). A rare missense   
 variant in RCL1 segregates with depression in extended families. Molecular Psychiatry.   
 23(5):1120-26. 
 Cover Image. Molecular Psychiatry. 23(5):1093 
Schreiber J*, Grimbergen L-A*, Overwater I, Van der Vaart T, Stedehouder J,    
 Schuhmacher AJ, Guerra C, Kushner SA, Jaarsma D, Elgersma Y. (2017). Mechanisms   
 underlying cognitive deficits in a mouse model for Costello Syndrome are distinct from  
 other RASopathy mouse models. Scientific Reports. 7(1):1256 
Peter S*, Ten Brinke MM*, Stedehouder J, Reinelt CM, Wu B, Zhou, H, Zhou K, Boele HJ,  
 Kushner SA, Lee, MG, Schmeisser, MJ, Boeckers, TM, Schonewille M, Hoebeek FE,   
 De Zeeuw CI. (2016). Dysfunctional cerebellar Purkinje cells contribute to autism-like  
 behaviour in Shank2-deficient mice. Nature Communications. 1(7):12627. 
Derks B, Stedehouder J, Ito T. (2015). Social identity modifies face perception: An ERP  
 study of social categorization. Social, Affective, Cognitive Neuroscience, 10(5):672-9. 
* These authors contributed equally P

